Page last updated: 2024-08-22

angiotensin ii and cyclic gmp

angiotensin ii has been researched along with cyclic gmp in 349 studies

Research

Studies (349)

Timeframe	Studies, this research(%)	All Research%
pre-1990	56 (16.05)	18.7374
1990's	149 (42.69)	18.2507
2000's	90 (25.79)	29.6817
2010's	51 (14.61)	24.3611
2020's	3 (0.86)	2.80

Authors

Authors	Studies
Riou, JP; Saez, JM; Tell, GE	1
Agrawal, R; Goodman, AD; Rosman, PM; Steiner, AL	1
Evans, JW; Munday, KA; Parsons, BJ	1
Brooker, G; Price, MG; Terasaki, WL	1
Kitamura, S	1
Deth, R; van Breemen, C	1
Davies, CJ; Hems, DA; Siddle, K	1
Bartley, P; Catt, K; Douglas, J; Kondo, T; Saltman, S; Williams, C	1
Dousa, TP; Edwards, RM; Northrup, TE; Shah, SV; Torres, VE	1
Assender, JW; Hallett, MB; Newby, AC; Southgate, KM	1
Horio, T; Kohno, M; Murakawa, K; Takeda, T; Yasunari, K; Yokokawa, K	2
Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yokokawa, K	1
Ades, AM; Fluharty, SJ; Reagan, LP; Ye, X; Zarahn, ED	1
Chaki, S; Inagami, T	1
Donker, AJ; Hackeng, WH; Meuwissen, SG; van Vliet, AA	1
Matsuda, Y; Morishita, Y; Oda, S; Sano, T	1
Chiu, AT; Leung, KH; Roscoe, WA; Smith, RD; Timmermans, PB	1
Bochkov, V; Buhler, F; Resink, T; Tkachuk, V	1
Fukui, T; Horio, T; Ikeda, M; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K	1
Lovell, HB; Savin, VJ; Sharma, R; Wiegmann, TB	1
Arnal, JF; Michel, JB	1
Schoeppe, W; Stahl, RA; Thaiss, F; Wolf, G	1
Busse, R; Fandrey, J; Mülsch, A; Pfeilschifter, J; Rob, P; Vosbeck, K	1
Bagger, JP; Danielsen, H; Eiskjaer, H; Jensen, JD; Jespersen, B; Pedersen, EB; Sørensen, SS; Thomsen, K	1
Magness, RR	1
Jespersen, B; Pedersen, EB; Sørensen, SS	1
Haynes, J; Kithas, PA; Strada, SJ; Taylor, AE	1
Burnett, JC; Margulies, KB; McKinley, LJ; Perrella, MA	1
Espiner, EA; Frampton, C; Ikram, H; Richards, AM; Wittert, G; Yandle, TG	1
Garcia, R; Gauquelin, G; Schiffrin, EL	1
Bessho, H; Suzuki, J; Tobe, A	1
Bessert, D; Giacomelli, F; Grammas, P; Wiener, J	1
Barnett, R; Blaufox, S; Nord, EP; Ortiz, PA; Ramsammy, L; Singer, S	1
Myers, LM; Sumners, C	1
Haneda, M; Horide, N; Kajiwara, N; Kikkawa, R; Koya, D; Maeda, S; Shigeta, Y; Togawa, M	1
Deslongchamps, M; Schiffrin, EL; Tremblay, J; Turgeon, A	1
Franco-Saenz, R; Lotshaw, DP; Mulrow, PJ	1
Bralet, J; Danvy, D; Duhamel, L; Duhamel, P; Gros, C; Lecomte, JM; Noël, N; Plaquevent, JC; Schwartz, JC; Souque, A	1
Carandente, O; Chierchia, SL; Ferrario, A; Passoni, A; Pizzetti, G	1
Miasiro, N; Paiva, AC	1
Danielsen, H; Jespersen, B; Pedersen, EB	1
Lang, U; Tamm, C; Vallotton, NB	1
Eiskjaer, H; Jespersen, B; Pedersen, EB	1
Raij, L; Schorer, AE; Shultz, PJ	1
Maeda, S	1
Barthelemy, C; Carayon, A; Eurin, B; Eurin, J; Legrand, JC; Maistre, G; Masson, F; Rouby, JJ; Zongazo, MA	1
Angielski, S; Kuchta, G; Redlak, M; Szczepanska-Konkel, M	1
Dzau, VJ; Itoh, H; Pratt, RE	1
Hechtman, HB; Morel, NM; Petruzzo, PP; Shepro, D	1
Fujimoto, K; Kobayashi, T; Kubo, K; Matsuzawa, Y; Sakai, A; Sekiguchi, M; Shinozaki, S; Ueda, G; Voelkel, NF; Yoshikawa, S	1
Craven, PA; DeRubertis, FR	1
Lincoln, TM; Smith, JB	1
Hyman, AL; Kadowitz, PJ; Lippton, HL	1
Briand, V; Lacolley, P; Laurent, S; Michel, JB; Schmitt, H; Vaxelaire, JF	1
Chiou, S; Davis, JS; Ganguly, A; West, LA	1
Kurtz, A; Penner, R	1
Ardaillou, R; Béa, ML; Chansel, D	1
DeCandido, S; Hays, RM; Satriano, JA; Schlondorff, D; Singhal, PC	1
Emori, T; Hirata, Y; Marumo, F; Ohta, K; Shichiri, M	1
Neyses, L; Vetter, H	1
Braquet, P; Chabrier, PE; Roubert, P	1
Garvin, JL	1
Broqvist, M; Dahlström, U; Karlberg, BE; Karlsson, E; Marklund, T	1
Harik, SI; Homayoun, P; Lust, WD	1
Heisler, S; Morrier, E	1
Barrett, PQ; Isales, CM	1
Franco-Saenz, R; Mulrow, PJ; Takagi, M	1
Bumpus, FM; Husain, A; Pucell, AG	1
Hashiguchi, T; Higuchi, K; Kangawa, K; Matsuo, H; Minamino, N; Nawata, H; Ohashi, M	1
Nishimura, H; Yamaguchi, K	1
Cornwell, TL; Lincoln, TM	1
Okamoto, M	1
Cooper, T; Harwell, S; Miller, HT; Yesus, W	1
Braquet, P; Chabrier, PE; Longchamps, MO; Plas, P; Roubert, P	1
Hackenthal, E; Taugner, R	1
Roy, P; Sen, I	1
Baur, U; Bühler, FR; Jones, CR; Resink, TJ; Scott-Burden, T	1
Chambaz, EM; Feige, JJ; Madani, C	1
Wang, XY	1
Asano, Y; Hosoda, S; Kawashima, H; Kusano, E; Murayama, N; Sokabe, H; Takeda, S	1
Kleinert, HD; Maack, T	1
Elliott, ME; Goodfriend, TL	1
Kanba, KS; Kanba, S; Pfenning, M; Richelson, E	1
Abou-Samra, AB; Aguilera, G; Catt, KJ	1
Alexander, RW; Berk, BC; Brock, TA; Gimbrone, MA	1
Alexander, RW; Berk, BC; Ganz, P; Gimbrone, MA; Griendling, KK	1
Cornwell, TL; Lincoln, TM; Rashatwar, SS	1
Murad, F	1
Böhme, E; Jakobs, KH; Schultz, G; Schultz, K	1
Manganiello, VC; Stoner, J; Vaughan, M	1
Kimura, H; Murad, F	1
Gilbert, JA; Pfenning, MA; Richelson, E	1
Ausiello, DA; Karnovsky, MJ; Kreisberg, JI; Roy, C	1
Schimmer, BP	1
Ardaillou, R; Richet, G; Sraer, J; Sraer, JD	1
Peach, MJ	1
Andreis, PG; Armato, U; Mantero, F	1
Bottari, SP; Brechler, V; De Gasparo, M; Levens, NR	1
Cahill, PA; Foster, C; Redmond, EM; Sitzmann, JV	1
Eiskjaer, H; Jensen, JD; Jespersen, B; Mogensen, CE; Pedersen, EB; Sørensen, SS	1
Benessiano, J; Boulanger, CM; Caputo, L; Lévy, BI	1
Campbell, SE; Ganjam, VK; Katwa, LC; Ou, R; Reddy, HK; Sigusch, HH; Weber, KT	1
Boulanger, CM; Caputo, L; Lévy, BI	1
Higashi, Y; Hiraga, H; Kajiyama, G; Kambe, M; Matsuura, H; Ono, N; Oshima, T; Watanabe, M; Yoshimura, M	1
Blantz, RC; Gabbai, FB; Malvey, K; Peterson, O; Thomson, SC; Wead, L	1
Adachi, S; Akimoto, H; Fujisaki, H; Hata, M; Hirata, Y; Hiroe, M; Ito, H; Lin, M; Marumo, F; Tanaka, M	1
Aldigier, JC; Baussant, T; Chassain, AP; Dalmay, F; Galen, FX; Huang, H; Lartigue, M; Leroux-Robert, C	1
Gomi, T; Hirawa, N; Ikeda, T; Kawabata, Y; Numabe, A; Ohshima, N; Ono, H; Toyo-oka, T; Uehara, Y; Yagi, S	1
Bottari, SP; Buisson, B; de Gasparo, M; Gallo-Payet, N; Laflamme, L; Payet, MD	1
Charles, CJ; Espiner, EA; Nicholls, MG; Richards, AM; Yandle, TG	1
Barnett, RL; Friedlaender, MM; Nord, EP; Pasmantier, R; Ramsammy, L; Ruffini, L	1
Blaschke, TF; Haefeli, WE; Hoffman, BB; Kongpatanakul, S; Srivastava, N	1
Eitle, E; Harris, PJ; Morgan, TO	1
Smith, RD	1
Heitsch, H; Linz, W; Schölkens, BA; Wagner, A; Wiemer, G	1
Dubey, RK	1
Espiner, EA; Hunt, PJ; Nicholls, MG; Richards, AM; Yandle, TG	2
Brock, A; Charles, P; Danielsen, H; Jespersen, B; Pedersen, EB; Sørensen, SS	1
Bähr, V; Hensen, J; Oelkers, W; Sander-Bähr, C	1
Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Linz, W; Schnell, A; Schölkens, BA; Unger, T; Wiemer, G	1
Haneda, M; Kikkawa, R; Koya, D; Maeda, S; Shigeta, Y; Togawa, M; Uzu, T	1
Jumblatt, JE; Ohia, SE	1
Fluharty, SJ; Maretzski, CH; Reagan, LP; Ye, X	1
Eiskjaer, H; Pedersen, EB	1
Raizada, MK; Richards, EM; Sumners, C; Tang, W	1
Bottari, SP; Brechler, V; de Gasparo, M; Jones, PW; Levens, NR	1
Mattana, J; Singhal, PC	1
Fittingoff, M; Hino, T; Hori, MT; Saito, F; Tuck, ML	1
Flueckiger, F; Horina, J; Preidler, K; Riepl, T; Saeed, M; Stiskal, MA; Szolar, DH; Watzinger, N	1
Eiskjaer, H; Jespersen, B; Mogensen, CE; Pedersen, EB; Sørensen, SS	1
Bürki, E; Burnier, M; Centeno, C; Centeno, G; Waeber, G	1
Chevalier, RL; McDowell, KA; Norling, LL; Thornhill, BA	1
Cermak, R; Forssmann, WG; Kleta, R; Schlatter, E	1
Bailey, RR; Charles, CJ; Lewis, LK; Lynn, KL; Nicholls, MG; Pidgeon, GB; Rademaker, MT; Richards, AM; Yandle, TG	1
Dietz, R; Höhnel, K; Luft, FC; Scheuermann, M; Willenbrock, R	1
Garrido, MR; Israel, A; Saavedra, JM; Strömberg, C; Torres, M; Tsutsumi, K	1
Komalavilas, P; Lincoln, TM	1
Sansom, SC; Stockand, JD	2
Naqvi, F; Oveisi, F; Purdy, RE; Smith, J; Vaziri, ND; Wang, ZQ; Zhou, XJ	1
Anderson, J; Bakhle, YS; Barker, JE; Piper, PJ; Treasure, T	1
Hassan, A; Magness, RR; Rosenfeld, CR; Shaul, PW	1
Gadsbøll, N; Høilund-Carlsen, PF; Kanstrup, IL; Lønborg-Jensen, H; Marving, J	1
Hirayama, Y; Ibukiyama, C; Iga, K; Ishii, T; Kiyomi, S; Nagai, Y; Ogawa, T; Takata, Y	1
Saavedra, JM; Seltzer, AM; Zorad, S	1
Gibbons, GH; Horiuchi, M; Pollman, MJ; Yamada, T	1
Eiskjaer, H; Nielsen, CB; Pedersen, EB; Sørensen, SS	1
Bagger, JP; Jensen, LW; Pedersen, EB	1
Asano, Y; Iimura, O; Nagashima, H; Tabei, K	1
Carey, RM; Jaffa, AA; Margolius, HS; Siragy, HM	1
Baines, RJ; Boarder, MR; Brown, C; Ng, LL	1
Abboa-Offei, BE; Asaad, MM; Dorso, CR; Mathers, PD; Rogers, WL; Seymour, AA; Smith, PL	1
Chun, TH; Doi, K; Igaki, T; Inoue, M; Itoh, H; Masatsugu, K; Nakao, K; Ogawa, Y; Takaya, K; Tamura, N; Yamashita, J	1
Cartledge, WA; Kumar, R; Lincoln, TM; Pandey, KN	1
Ardaillou, R; Chatziantoniou, C; Dussaule, JC; Essig, M; Vandermeersch, S	1
Brizzolara-Gourdie, A; Webb, JG	1
Aikawa, J; Fukazawa, M; Ishikawa, M; Moroi, M; Namiki, A; Yamaguchi, T	1
Tomera, JF	1
Fukai, D; Kinoshita, M; Maeda, Y; Tsutamoto, T; Wada, A	1
Herbert, J; Zhu, B	1
de Koster, BM; Elferink, JG	1
Carey, RM; Siragy, HM	2
Beuck, M; Dressel, J; Fey, P; Frobel, K; Hirth-Dietrich, C; Hübsch, W; Kazda, S; Knorr, A; Krämer, T; Sander, E; Stasch, JP	1
Brecher, P; Chobanian, AV; Gu, M; Takizawa, T	1
Brunner, F; Kern, T; Meinhart, J; Schmidt, K; Schuller-Petrovic, S; Siedler, S	1
Egashira, K; Funakoshi, Y; Ichiki, T; Ito, K; Kato, M; Takeshita, A; Usui, M	1
Gohlke, P; Pees, C; Unger, T	2
Charles, CJ; Espiner, EA; Kosoglou, T; Nicholls, MG; Rademaker, MT; Richards, AM	1
Jimi, N; Minami, K; Nakashima, Y; Segawa, K; Shigematsu, A	1
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Gorski, TP; James, GM; Kladis, A; Leung, R	1
Couser, WG; Humphreys, MH; Valentin, JP; Ying, WZ	1
Eitle, E; Harris, PJ; Hiranyachattada, S; Wang, H	1
Derr, T; Hall, D; Kubacak, B; Sansom, SC; Silverman, M; Stockand, JD	1
Carey, RM; Guerrant, RL; Jin, XH; Siragy, HM; Wang, ZQ	1
Ikezaki, H; Onyüksel, H; Rubinstein, I	1
Carstens, J; Jensen, KT; Pedersen, EB	1
Mayeux, PR; Zhang, C	2
LaPointe, MC; Marsh, JD; Ritchie, RH; Schiebinger, RJ	1
Fabian, M; Nishimura, H; Shimada, T; Yan, HQ	1
Cashdollar, LW; Drewett, JG; Ho, BY; Olson, LJ	1
Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A	2
Charles, CJ; Espiner, EA; Nicholls, MG; Rademaker, MT; Richards, AM	1
Block, ER; Gelband, CH; Li, YD; Martens, JR; Patel, JM; Raizada, MK	1
Schmid, HA	1
Cohen, RA; Griswold, MC; Komalavilas, P; Lincoln, TM; Weisbrod, RM; Yaghoubi, M	1
Carey, RM; Guerrant, RL; Jin, XH; Siragy, HM	1
Amado, JA; Berrazueta, JR; Fernández, C; García-Unzueta, MT; Montalbán, C; Ochoteco, A; Peña, N; Poveda, JJ	1
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T	1
Conrad, KP; Danielson, LA; Sherwood, OD	1
Barati, M; Butulija, D; Hamid, H; Kulkarni, PS	1
Brenner, BM; Dietz, R; Höhnel, K; Mackenzie, HS; Pagel, I; Scheuermann, M; Willenbrock, R	1
Biollaz, J; Brunner, HR; Brunner-Ferber, F; Buclin, T; Décosterd, LA; La Roche, SD; Nussberger, J; Rousso, P	1
Brown, C; Hassid, A; Pan, X	1
Lew, WY; Yasuda, S	1
Carey, RM; Ichiki, T; Inagami, T; Siragy, HM	1
Iida, Y; Katusic, ZS; O'Brien, T; Onoue, H; Smith, L; Tsutsui, M	1
Bivalacqua, TJ; Champion, HC; D'Souza, FM; Heistad, DD; Hyman, AL; Jeter, JR; Kadowitz, PJ; Ortiz, LA; Toyoda, K	1
Carlson, EJ; Drewett, JG; Kreklau, EL	1
Fujiyama, A; Fujiyama, S; Iwasaka, T; Kawada, N; Koyama, Y; Kurihara, H; Masaki, H; Matsubara, H; Miwa, T; Miyazaki, M; Mori, Y; Murasawa, S; Nakagawa, K; Nozawa, Y; Ozono, R; Shibasaki, Y; Takahashi, H; Takai, S; Tanaka, Y; Tsutsumi, Y	1
Bohlender, J; Dietz, R; Haass, M; Höhnel, K; Luft, FC; Scheuermann, M; Thibault, G; Willenbrock, R	1
Kawano, H; Kimura, S; Kitamura, H; Kunieda, Y; Masuda, H; Nakagawa, K; Nakagawa, M; Nishimura, H; Sugano, T; Tsuji, H; Yoshizumi, M	1
Brunton, LL; Endo-Mochizuki, Y; Gonzalez, AM; Meszaros, JG; Villarreal, F; Villegas, S	1
Boyle, JW; Li, M; Nguyen, HT; Pandey, KN	1
Ishii, K; Isobe, K; Kawakami, Y; Nakai, T; Nanmoku, T; Takekoshi, K	1
Dusting, GJ; Ritchie, RH; Rosenkranz, AC	1
Carey, RM; Siragy, HM; Wang, ZQ	1
Siragy, HM	1
Espiner, EA; Frampton, CM; Nicholls, MG; Powell, JD; Rademaker, MT; Richards, AM; Troughton, RW; Yandle, TG	1
Block, ER; Chen, S; Patel, JM	1
Basso, N; González Bosc, L; Kurnjek, ML; Müller, A	1
Barthélemy, C; Carayon, A; Eurin, J; Masson, F; Soualmia, H	1
Burns, KD; Chen, JK; Harris, RC; Zimpelmann, J	1
Carey, RM; Heiderstadt, NT; Howell, NL; Huang, E; Moore, AF; Siragy, HM; Wang, ZQ	1
Zhan, CD	1
Betancourt-Calle, S; Bollag, WB; Calle, RA; Kent, P; White, S	1
Tsui, JK; Wong, NL	1
Alvarez, A; Blazquez, MA; Piqueras, L; Sanz, MJ	1
Antonio, MT; Bragulat, E; Coca, A; de la Sierra, A; Jiménez, W	1
Ishii, K; Isobe, K; Kawakami, Y; Nakai, T; Takekoshi, K	1
Hildebrandt, DA; Lohmeier, JR; Lohmeier, TE; Reckelhoff, JF	1
Abdelaziz, N; Calderone, A; Colombo, F; Mercier, I	1
Ishii, K; Isobe, K; Kawakami, Y; Nakai, T; Shibuya, S; Takekoshi, K	2
Beavo, JA; Berk, BC; Kim, D; Munzel, T; Pi, X; Rybalkin, SD; Wang, Y; Yan, C; Zhang, C	1
Eskelinen, S; Luodonpää, M; Ruskoaho, H; Vuolteenaho, O	1
Daigle, C; Dao, HH; deBlois, D; Demeilliers, B; Girardot, D; Martens, FM; Moreau, P	1
Aubert, ML; Blum, WF; Dietz, R; Höhnel, K; Langenickel, T; Nüssler, AK; Pagel, I; Philipp, S; Willenbrock, R	1
Charles, CJ; Cooper, GJ; Coy, DH; Espiner, EA; Lewis, LK; Nicholls, MG; Rademaker, MT; Richards, AM	1
Bayorh, MA; Eatman, D; Emmett, N; Socci, RR; Thierry-Palmer, M; Walton, M	1
August, M; Bodenschatz, M; Förstermann, U; Griendling, K; Kleschyov, AL; Lassègue, B; Li, H; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Schulz, E; Szöcs, K; Tsilimingas, N; Walter, U; Wendt, M	1
Hou, X; Hu, X; Kang, J; Wang, W; Xiao, D; Yu, R	1
Carey, RM; De Gasparo, M; El-Kersh, MA; Siragy, HM; Webb, RL	1
Abe, Y; Fukui, T; Kimura, S; Kosaka, H; Nishiyama, A; Rahman, M; Yoneyama, H	1
Antonov, AS; Gerrity, RG; Nguyen, HT; Pandey, KN; Sharma, GD; von Geldern, T	1
Burns, V; Gavini, N; Gray, A; Johnson, J; Knowle, D; Pulakat, L	1
Wang, W; Wei, Y	1
Angielski, S; Bryl, E; Dubaniewicz, A; Golos, M; Latawiec, E; Lewko, B; Olszewska, A; Stepinski, J; Witkowski, JM	1
Aizawa, T; Berk, BC; Kim, D; Yan, C	1
Benitez, AH; Bodo, CC; Cabilla, JP; Duvilanski, BH; Velardez, MO	1
Antunes-Rodrigues, J; Gutkowska, J; McCann, SM	1
Dusting, GJ; Ritchie, RH; Rosenkranz, AC; Woods, RL	1
Harada, E; Harada, M; Ito, T; Kurihara, H; Mizuno, Y; Nakamura, S; Nakao, K; Nakayama, M; Ogawa, H; Saito, Y; Shimasaki, Y; Yamamuro, M; Yasue, H; Yoshimura, M	1
Hartshorne, DJ; Isaka, N; Ito, M; Kureishi, Y; Moriki, N; Nakano, T; Okamoto, R; Onishi, K; Seko, T	1
Itoh, T; Kajikuri, J; Mabuchi, Y; Suzuki, Y; Tada, T	1
Biermann, T; Culman, J; Gohlke, P; Luther, C; Unger, T; Zhao, Y	1
Abukhalaf, IK; Bayorh, MA; Eatman, D; Ganafa, AA; Silvestrov, N; Socci, RR	1
Feil, R; Hofmann, F	1
Charles, CJ; Espiner, EA; Frampton, CM; Nicholls, MG; Rademaker, MT; Richards, AM	1
Boemke, W; Drzimalla, M; Höhne, C; Kaczmarczyk, G; Krebs, MO	1
Davis, EA; Gaspari, TA; Hannan, RE; Widdop, RE	1
Batenburg, WW; Bernasconi, CC; Danser, AH; Garrelds, IM; Juillerat-Jeanneret, L; Saxena, PR; van Kats, JP	1
Hiyoshi, H; Okamoto, H; Takano, M; Yayama, K	1
Isaka, N; Ito, M; Kaibuchi, K; Kongo, M; Kureishi, Y; Moriki, N; Nakakuki, T; Nakano, T; Okamoto, R; Seko, T	1
Dendorfer, A; Dominiak, P; Jöhren, O	1
Calò, LA; Ceolotto, G; Davis, PA; Pagnin, E; Pessina, AC; Sartori, M; Semplicini, A	1
Katsuura, G	1
Aizawa, T; Berk, BC; Kim, D; Pi, X; Rybalkin, SD; Wei, H; Yan, C	1
Amelio, D; Cerra, MC; Ip, YK; Pellegrino, D; Tota, B	1
Baker, KM; Dostal, DE; Kumar, R; Sanghi, S; Smith, M	1
Foster, E; Kahn, AM; Yang, M	1
Alvarez, E; Campos-Toimil, M; Justiniano-Basaran, H; Lugnier, C; Orallo, F	1
Hakam, AC; Hussain, T	1
Chigogidze, T; Jonas, U; Kediia, G; Kediia, M; Managadze, LG; Truss, MC; Uckert, S	1
Siragy, HM; Webb, RL; Xue, C	1
Aubin, MC; Carrier, M; Perrault, LP; Shi, YF; Tardif, JC	1
Brandes, RP; Daiber, A; Förstermann, U; Hink, U; Hortmann, M; Kleschyov, AL; Li, H; Mollnau, H; Mülsch, A; Münzel, T; Oelze, M; Schulz, E; von Sandersleben, A; Wenzel, P	1
Charles, CJ; Rademaker, MT; Richards, AM	1
Angielski, S; Gołos, M; Latawiec, E; Lewko, B; Stepinski, J	1
Imig, JD; Kang, KT; Pollock, JS; Sasser, JM; Sullivan, JC	1
Anning, PB; Baalasubramanian, S; Coles, B; Lewis, R; Morgan, BP; Morton, J; O'Donnell, VB	1
Damm, DL; Kapoun, AM; Lam, A; Liang, F; O'Connell, M; Protter, AA; Quan, D	1
Chen, J; Fan, F; Han, L; Wang, S; Wang, X; Xie, X; Yan, J; Zhou, X	1
Schewe, T; Sies, H; Steffen, Y	1
Pandey, KN; Somanna, N; Vellaichamy, E; Zhao, D	1
Carey, RM; Inagami, T; Siragy, HM	1
Chen, XY; Du, GT; Ji, H; Li, YQ; Meng, ZK; Shi, WB; Tian, J; Zhang, YH	1
Guan, YF; Shen, FM; Su, DF; Tao, X; Zhang, YJ	1
Fan, FH; Wang, SJ; Wang, XX	1
Addanki, V; Fung, HL; Tsou, PS	1
Bünemann, M; Gassner, B; Gazinski, A; Hartmann, M; Kuhn, M; Müller, T; Nikolaev, VO; Schröter, J; Skryabin, BV	1
Artmeier-Brandt, U; Frey, R; Mück, W; Unger, S; Weimann, G; Wensing, G	1
Banday, AA; Lokhandwala, MF	1
Autieri, MV; Brailoiu, E; Dhanasekaran, DN; Eguchi, K; Eguchi, S; Fields, TA; Frank, GD; Higuchi, S; Hinoki, A; Ishimaru, K; Kimura, K; Shirai, H; Stemmle, LN; Suzuki, H	1
Gao, P; Huang, L; Li, W; Qian, DH	1
Baer, L; Gallo, G; Haddy, FJ; Kumar, AR; Manger, WM; Reidy, JJ; Simchon, S; Stokes, MB	1
Arany, ZP; Hofmann, F; Itoh, H; Miyashita, K; Nakao, K; Sawada, N; Sone, M; Tsujimoto, H; Yamahara, K	1
Abe, J; Beavo, JA; Blaxall, BC; Cai, Y; Chen, YF; Florio, V; Li, JD; Miller, CL; Nagel, DJ; Oikawa, M; Rybalkin, SD; Wojtovich, AP; Xu, H; Xu, X; Yan, C	1
Hong, E; Villafaña, S	1
Takimoto, E	1
Almeida, PW; Bader, M; Campagnole-Santos, MJ; Gomes, ER; Guatimosim, S; Guimarães, D; Lara, AA; Resende, RR; Santos, RA	1
Kim, SH; Oh, YB; Park, BH; Shah, A; Shan, G; Song, CH	1
Fukushima, K; Kagota, S; Kunitomo, M; Mori, H; Nakamura, K; Nejime, N; Shinozuka, K; Sugimura, K; Tada, Y; Umetani, K	1
Li, J; Tang, YB; Xie, ZZ	1
Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Ichiki, T; Martin, FL; McKie, PM; Sangaralingham, SJ	1
d'Uscio, LV; Kang, KT; Katusic, ZS; Pollock, JS; Spradley, FT; Sullivan, JC	1
Etienne-Selloum, N; Kane, MO; Keravis, T; Lugnier, C; Mokni, W; Schini-Kerth, VB; Walter, A	1
Han, B; He, Y; Ma, J; Pan, Y; Peng, T; Wang, Y; Wei, M; Xin, P; Zhu, W	1
Carneiro, FS; Giachini, FR; Lima, VV; Tostes, RC; Webb, RC	1
Guo, B; Han, R; Li, Y; Wang, M; Zhou, H	1
Clasen, T; Friedrich, S; Königshausen, E; Mergia, E; Potthoff, SA; Quack, I; Rump, LC; Sellin, L; Stegbauer, J; Vonend, O; Woznowski, M	1
Bae, EH; Kim, SW; Lee, J; Ma, SK	1
Aubin, MC; Carrier, M; Forcillo, J; Maltais, S; Perrault, LP; Shi, YF; Tardif, JC	1
Akiyama, K; Hata, M; Hirayama, A; Sezai, A; Shiono, M; Unosawa, S; Wakui, S; Yoshitake, I	1
Allahdadi, KJ; Choi, H; Tostes, RC; Webb, RC	1
Li, YF; Patel, KP; Sharma, NM; Zheng, H	1
Chen, P; Tee, WT; Than, A	1
Bani, D; Di Cesare Mannelli, L; Failli, P; Feil, R; Mazzetti, L; Nistri, S	1
Alexander, AE; Cao, AH; Irvine, JC; Kaye, DM; Kemp-Harper, BK; Lin, EQ; Love, JE; McMullen, JR; Patel, R; Ritchie, RH	1
Gao, X; Su, L; Wang, X; Xing, H; Yang, Y	1
Baskaran, P; Beuve, A; Couloubaly, S; Crassous, PA; Durán, WN; Fioramonti, X; Huang, C; Kim, DD; Papapetropoulos, A; Zhou, Z	1
Amin, A; Badr El-Din, NK; Choi, SK; Kadowitz, P; Kevil, CG; Matrougui, K; Navar, LG; Osman-Elazeik, Y; Trebak, M	1
Das, J; Gutkind, JS; Ray, PE; Short, BL; Xie-Zukauskas, H	1
Adams, GN; Bilodeau, ML; Chen, A; Fang, C; Grobe, N; LaRusch, G; Mahdi, F; Morris, M; Nieman, MT; Schmaier, AA; Schmaier, AH; Stavrou, E; Warnock, M; Zhou, Y	1
Forster, K; Lutz, TA; Riediger, T; Züger, D	1
Andreozzi, F; Carnevale, D; Casaburo, M; Hribal, ML; Perticone, F; Perticone, M; Presta, I; Sciacqua, A; Sesti, G; Tassone, EJ	1
Cha, SA; Gao, S; Kim, SH; Park, BM	1
Balligand, JL; Beauloye, C; Belge, C; Bertrand, L; Dessy, C; Dubois-Deruy, E; Esfahani, H; Götz, KR; Hamelet, J; Hammond, J; Herijgers, P; Hilfiker-Kleiner, D; Iaccarino, G; Jnaoui, K; Langin, D; Lobysheva, I; Manoury, B; Markl, A; Nikolaev, VO; Pouleur, AC; Tavernier, G; Vanderper, A	1
Enomoto, Y; Hofmann, F; Homma, Y; Horita, S; Kawakami, H; Kudo, A; Kume, H; Nakamura, M; Nishiyama, A; Satoh, N; Seki, G; Shirai, A; Suzuki, M; Yamada, H; Yamazaki, O	1
Beavo, JA; Blaich, A; Desch, M; Domes, K; Hofmann, F; Lukowski, R; Patrucco, E; Rybalkin, SD; Sbroggió, M; Schlossmann, J	1
Li, D; Luo, Y; Ma, Y; Pan, D; Wang, T; Xu, T; Zhang, Y	1
Chen, Y; Meng, G; Yang, S; Yao, W; Zhang, W; Zhu, H	1
Bork, N; Dünnes, S; Friebe, A; Gawaz, M; Lukowski, R; Nemer, M; Nikolaev, VO; Russwurm, M; Schöttle, V; Straubinger, J; Subramanian, H	1
Edwards, A; Layton, AT	1
Adler, GK; Khalil, RA; Opsasnick, LA; Pojoga, LH; Reslan, OM; Siddiqui, WT; Williams, GH; Yao, TM	1
Angielski, S; Daca, A; Gołos, M; Latawiec, E; Lewko, B; Maryn, A; Stępiński, J; Waszkiewicz, A; Witkowski, JM	1
Broekmans, K; Koesling, D; Mergia, E; Potthoff, SA; Russwurm, M; Stegbauer, J	1
Li, C; Wang, G; Wu, J; Yuan, W; Zhang, Q	1
Carretero, OA; Garvin, JL; Ortiz, PA; Ramseyer, VD	1
Cong, XL; Geng, XY; Li, J	1
Ait-Aissa, K; Belmadani, S; Gabani, M; Haddox, S; Irani, K; Kassan, M; Mali, V; Matrougui, K; Radwan, E; Trebak, M; Zhang, W	1
Grave, K; Hering, L; Hoch, H; Mergia, E; Potthoff, SA; Rump, LC; Sivritas, SH; Stegbauer, J; Thieme, M; Yang, G	1
Boldt, K; Bork, N; Deng, L; Desch, M; Feil, R; Feil, S; Just, S; Krattenmacher, D; Kuret, A; Lukowski, R; Nemer, M; Ruth, P; Straubinger, J; Ueffing, M	1
Chang, NB; He, YZ; Jiang, J; Jiang, R; Li, T; Sun, XL; Xu, JY	1
Ling, WC; Murugan, DD; Mustafa, MR; Vanhoutte, PM	1
Baganha, F; Carneiro, F; Castro-Chaves, P; Cerqueira, RJ; Gonçalves, F; Heymans, S; Laundos, TL; Leite-Moreira, AF; Mendonça, L; Nascimento, DS; Paiva, JA; Pinto-do-Ó, P; Quina-Rodrigues, C; Reguenga, C; Ribeiro, S; Roncon-Albuquerque, R; Schroen, B; Soares-Dos-Reis, R; Vasques-Nóvoa, F; Verhesen, W	1
Danhof, M; Giraudel, J; Mochel, JP; Peyrou, M; Rigel, DF; Teng, CH	1
Chen, A; Han, Y; Li, P; Luo, Y; Ren, X; Sun, S; Tang, H; Xu, Y; Zhang, F	1
Burnett, JC; Chen, Y; Grande, JP; Harty, GJ; Ichiki, T; Iyer, SR; Lee, HC; Sangaralingham, SJ; Sugihara, S; Wang, X; Zheng, Y	1
Das, S; Pandey, KN; Periyasamy, R	1
Bao, C; Chen, A; Han, Y; Li, P; Pan, Y; Sun, S; Tang, H; Wang, J; Xu, Y; Zhang, F	1
Chen, PP; Deng, J; Gao, Y; Gong, QH; Li, YY; Lin, HC; Luo, M; Shi, WL; Wen, ZQ; Xu, RX; Xu, SF	1
Lee, SK; Ling, WC; Mohd Sabri, NA; Murugan, DD	1
Burnett, JC; Cannone, V; Chen, HH; Chen, Y; Ferrario, CM; Iyer, SR; Ma, X; Moroni, DG; Pan, S; Reginauld, SH; Sangaralingham, SJ; Yu, Y; Zhang, L; Zheng, Y	1

Reviews

15 review(s) available for angiotensin ii and cyclic gmp

Article	Year
[Membrane hormone receptors]. Lyon medical, 1975, Jun-08, Volume: 233, Issue:11 Topics: Adenylyl Cyclases; Angiotensin II; Animals; Calcitonin; Catecholamines; Cell Division; Cell Membrane; Cholera; Cyclic AMP; Cyclic GMP; Humans; Pancreatic Hormones; Parathyroid Hormone; Pituitary Hormone-Releasing Hormones; Pituitary Hormones; Pituitary Hormones, Anterior; Pituitary Hormones, Posterior; Prostaglandins; Receptors, Cell Surface; Toxins, Biological	1975
[The lung as a metabolic organ]. Masui. The Japanese journal of anesthesiology, 1976, Oct-01, Volume: 25, Issue:20 Topics: Angiotensin II; Animals; Bradykinin; Cyclic AMP; Cyclic GMP; Dogs; Gastrointestinal Hormones; Histamine; Kynurenine; Lung; Prostaglandins; Serotonin; SRS-A	1976
[Signals regulating arterial vasomotricity and vasotrophicity]. Presse medicale (Paris, France : 1983), 1992, Jul-22, Volume: 21, Issue:26 Topics: Angiotensin II; Arteries; Calcium Channels; Calcium-Transporting ATPases; Cyclic GMP; Endothelium, Vascular; Guanylate Cyclase; Humans; Inositol Phosphates; Muscle, Smooth, Vascular; Vasoconstriction; Vasodilation	1992
Endothelium-derived vasoactive substances and uterine blood vessels. Seminars in perinatology, 1991, Volume: 15, Issue:1 Topics: Angiotensin II; Animals; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Female; Hemodynamics; Humans; Indomethacin; Muscle, Smooth, Vascular; Nitric Oxide; Pregnancy; Pregnancy, Animal; Sheep; Uterus	1991
Hormonal signals and intracellular messengers for renin secretion. Molecular and cellular endocrinology, 1986, Volume: 47, Issue:1-2 Topics: Acetylcholine; Adenosine; Adenylyl Cyclases; Adrenergic alpha-Agonists; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic AMP; Cyclic GMP; Dopamine; Epinephrine; Histamine; Hormones; Nerve Tissue Proteins; Neuropeptide Y; Norepinephrine; Platelet Activating Factor; Prostaglandins; Renin; Vasopressins	1986
Renal and cardiovascular effects of atrial natriuretic factor. Biochemical pharmacology, 1986, Jul-01, Volume: 35, Issue:13 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium-Transporting ATPases; Cardiac Output; Cardiovascular System; Cyclic GMP; Epinephrine; Glomerular Filtration Rate; Heart Rate; Kidney; Renin; Structure-Activity Relationship; Vascular Resistance; Vasoconstrictor Agents; Vasodilation	1986
Inhibition of aldosterone synthesis by atrial natriuretic factor. Federation proceedings, 1986, Volume: 45, Issue:9 Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cattle; Cholesterol; Cholesterol Side-Chain Cleavage Enzyme; Cyclic GMP; Phosphatidylinositols; Protein Biosynthesis; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Structure-Activity Relationship	1986
Cyclic nucleotides in hormonal regulation of adrenocortical function. Advances in cyclic nucleotide research, 1980, Volume: 13 Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Angiotensin II; Animals; Cyclic AMP; Cyclic GMP; Humans; Nucleotides, Cyclic; Nutritional Physiological Phenomena; Phosphorylation; Prostaglandins; Protein Kinases; Steroids	1980
Molecular actions of angiotensin. Biochemical pharmacology, 1981, Volume: 30, Issue:20 Topics: Adenylyl Cyclase Inhibitors; Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Calcium; Cell Membrane; Cells, Cultured; Cyclic AMP; Cyclic GMP; Enzyme Activation; Guanosine Triphosphate; Heart; Liver; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Phospholipases A; Phosphoprotein Phosphatases; Phosphorylases; Protein Kinases; Receptors, Angiotensin; Tissue Distribution; Type C Phospholipases	1981
Effect of glutamate and angiotensin II on whole cell currents and release of nitric oxide in the rat subfornical organ. Amino acids, 1998, Volume: 14, Issue:1-3 Topics: Angiotensin II; Animals; Cyclic GMP; Glutamic Acid; Neurons; Nitric Oxide; Rats; Subfornical Organ	1998
Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation. Current hypertension reports, 2000, Volume: 2, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Cyclic GMP; Humans; Natriuresis; Nitric Oxide; Receptors, Angiotensin	2000
Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator. Arteriosclerosis, thrombosis, and vascular biology, 2003, Jan-01, Volume: 23, Issue:1 Topics: Angiotensin II; Animals; Cyclic GMP; Feedback, Physiological; Humans; Models, Biological; Nitric Oxide; Signal Transduction	2003
Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovascular research, 2004, Jun-01, Volume: 62, Issue:3 Topics: Angiotensin II; Animals; Aorta; Apoptosis; Cyclic GMP; Humans; Kidney; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Myocardium; Nitric Oxide; Rats; Receptor, Angiotensin, Type 2; Signal Transduction	2004
[Central action of natriuretic peptides]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9 Topics: Angiotensin II; Animals; Astrocytes; Blood Pressure; Brain; Cyclic GMP; Drinking; Guanylate Cyclase; Humans; Natriuretic Peptides; Receptors, Atrial Natriuretic Factor; Receptors, Enterotoxin; Receptors, Guanylate Cyclase-Coupled; Receptors, Peptide; Sympathetic Nervous System; Vasopressins; Water-Electrolyte Balance	2004
NO modulation of myocardial performance in fish hearts. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology, 2005, Volume: 142, Issue:2 Topics: Angiotensin II; Angiotensins; Animals; Cyclic GMP; Endocardium; Endothelium, Vascular; Fishes; Gene Expression Regulation; Heart; Heart Ventricles; Microscopy, Fluorescence; Models, Biological; Myocardial Contraction; Myocardium; Nitric Oxide; Protein Isoforms; Receptors, Cholinergic; Signal Transduction; Time Factors	2005

Trials

12 trial(s) available for angiotensin ii and cyclic gmp

Article	Year
Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects. Journal of hypertension, 1991, Volume: 9, Issue:10 Topics: Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Circadian Rhythm; Creatinine; Cyclic GMP; Double-Blind Method; Endocrine Glands; Hemodynamics; Humans; Indans; Kidney; Natriuresis; Neprilysin; Propionates; Reference Values; Renin	1991
Intravenous administration of L-arginine inhibits angiotensin-converting enzyme in humans. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:7 Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Arginine; Blood Pressure; Cyclic GMP; Glomerular Filtration Rate; Heart Rate; Humans; Infusions, Intravenous; Insulin; Male; Peptidyl-Dipeptidase A; Reference Values; Renal Circulation; Renin; Time Factors; Vascular Resistance	1995
Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. Journal of cardiovascular pharmacology, 1993, Volume: 21, Issue:2 Topics: Adult; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cyclic GMP; Double-Blind Method; Exercise; Exercise Test; Hemodynamics; Hormones; Humans; Male; Renin-Angiotensin System; Urodynamics	1993
Bioactivity and metabolism of C-type natriuretic peptide in normal man. The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:6 Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Creatinine; Cyclic GMP; Epinephrine; Hormones; Humans; Hydrocortisone; Infusions, Intravenous; Male; Metabolic Clearance Rate; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Norepinephrine; Potassium; Reference Values; Single-Blind Method; Sodium; Time Factors	1994
Dose-response study of atrial natriuretic peptide bolus injection in healthy man. European journal of clinical investigation, 1993, Volume: 23, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Injections, Intravenous; Kidney; Male; Middle Aged; Natriuresis; Potassium; Renal Circulation	1993
Renal and hormonal actions of atrial natriuretic peptide during angiotensin II or noradrenaline infusion in man. European journal of clinical investigation, 1996, Volume: 26, Issue:7 Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Cyclic GMP; Female; Glomerular Filtration Rate; Hormones; Humans; Infusions, Intravenous; Kidney; Kidney Tubules; Male; Middle Aged; Natriuresis; Norepinephrine; Renal Plasma Flow	1996
Metabolism and action of urodilatin infusion in healthy volunteers. Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cross-Over Studies; Cyclic GMP; Diuretics; Double-Blind Method; Heart Rate; Hematocrit; Humans; Infusions, Intravenous; Kidney; Lithium; Male; Metabolic Clearance Rate; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Renin; Sodium	1998
Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers. Journal of hypertension, 1999, Volume: 17, Issue:3 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Cross-Over Studies; Cyclic GMP; Diet, Sodium-Restricted; Endocrine System; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney; Male; Neprilysin; Peptidyl-Dipeptidase A; Posture; Pyridines; Reference Values; Renal Plasma Flow, Effective; Safety; Stereoisomerism	1999
Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension. Clinical science (London, England : 1979), 2001, Volume: 101, Issue:1 Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure Monitoring, Ambulatory; Cyclic GMP; Diet, Sodium-Restricted; Endothelins; Female; Humans; Hypertension; Male; Middle Aged; Nitrates; Nitrites; Normal Distribution; Renin; Single-Blind Method; Sodium Chloride, Dietary; Statistics, Nonparametric	2001
Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure. Clinical science (London, England : 1979), 2004, Volume: 106, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Bosentan; Cardiac Output; Cardiac Output, Low; Cardiac Pacing, Artificial; Cyclic GMP; Endothelin Receptor Antagonists; Endothelin-1; Female; Infusions, Parenteral; Losartan; Natriuretic Peptide, Brain; Renin; Sheep; Sulfonamides	2004
Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers. Journal of clinical pharmacology, 2008, Volume: 48, Issue:12 Topics: Adult; Angiotensin II; Area Under Curve; Benzoates; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activators; Guanylate Cyclase; Half-Life; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Molecular Structure; Norepinephrine; Receptors, Cytoplasmic and Nuclear; Renin; Soluble Guanylyl Cyclase; Treatment Outcome; Young Adult	2008
Myocardial protective effect of human atrial natriuretic Peptide in cardiac surgery. -hANP Shot” in clinical safety trial-. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9 Topics: Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cardiotonic Agents; Coronary Artery Bypass; Creatine Kinase, MB Form; Cyclic GMP; Dose-Response Relationship, Drug; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart Arrest, Induced; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Postoperative Complications; Renin; Troponin I	2011

Other Studies

322 other study(ies) available for angiotensin ii and cyclic gmp

Article	Year
Effect of angiotensin II on cyclic guanosine monophosphate and cyclic adenosine monophosphate in human plasma. The Journal of clinical endocrinology and metabolism, 1976, Volume: 42, Issue:3 Topics: Angiotensin II; Atropine; Cyclic AMP; Cyclic GMP; Humans; Male; Parasympathetic Nervous System; Radioimmunoassay	1976
Proceedings: Possible involvement of cyclic GMP in the responses of rat kidney cortex slices to angiotensin. The Journal of endocrinology, 1976, Volume: 68, Issue:3 Topics: Angiotensin II; Animals; Cyclic GMP; In Vitro Techniques; Kidney Cortex; Rats	1976
Gammaflow: a completely automated radioimmunoassay system. Science (New York, N.Y.), 1976, Oct-15, Volume: 194, Issue:4262 Topics: Angiotensin II; Autoanalysis; Cyclic AMP; Cyclic GMP; Digoxin; Insulin; Radioimmunoassay; Thyroxine	1976
Agonist induced release of intracellular Ca2+ in the rabbit aorta. The Journal of membrane biology, 1977, Jan-28, Volume: 30, Issue:4 Topics: Angiotensin II; Animals; Aorta; Biological Transport; Calcium; Cyclic GMP; Egtazic Acid; Histamine; Isoproterenol; Kinetics; Lanthanum; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phenoxybenzamine; Rabbits	1977
Effect of hormones on content of purine nucleoside cyclic monophosphates in perfused rat liver. FEBS letters, 1978, Mar-15, Volume: 87, Issue:2 Topics: Acetylcholine; Angiotensin II; Animals; Cyclic AMP; Cyclic GMP; Glucagon; Hormones; In Vitro Techniques; Insulin; Liver; Male; Oxytocin; Perfusion; Rats; Vasopressins	1978
An examination of possible mechanisms of angiotensin II-stimulated steroidogenesis. Endocrine research communications, 1978, Volume: 5, Issue:2 Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Bucladesine; Cyclic AMP; Cyclic GMP; Dogs; In Vitro Techniques; Kinetics; Sodium-Potassium-Exchanging ATPase	1978
Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II. The Journal of clinical investigation, 1978, Volume: 62, Issue:6 Topics: Angiotensin II; Animals; Carbachol; Cyclic AMP; Cyclic GMP; Histamine; Histamine Antagonists; In Vitro Techniques; Kidney Cortex; Kidney Glomerulus; Kidney Tubules; Male; Nucleotides, Cyclic; Parathyroid Hormone; Rats; Stimulation, Chemical	1978
Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells. The Biochemical journal, 1992, Dec-01, Volume: 288 ( Pt 2) Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Aorta; Calcium; Cell Division; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Muscle, Smooth; Platelet-Derived Growth Factor; Rabbits; Serotonin	1992
Atrial and brain natriuretic peptides inhibit the endothelin-1 secretory response to angiotensin II in porcine aorta. Circulation research, 1992, Volume: 70, Issue:2 Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endothelins; Endothelium, Vascular; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Radioimmunoassay; Swine	1992
C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate. Hypertension (Dallas, Tex. : 1979), 1992, Volume: 19, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Chromatography, High Pressure Liquid; Cyclic GMP; Endothelins; Endothelium, Vascular; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Swine; Thrombin	1992
Angiotensin-induced cyclic GMP production is mediated by multiple receptor subtypes and nitric oxide in N1E-115 neuroblastoma cells. Journal of neurochemistry, 1992, Volume: 58, Issue:5 Topics: Angiotensin II; Animals; Cyclic GMP; Inositol 1,4,5-Trisphosphate; Neuroblastoma; Nitric Oxide; Radioimmunoassay; Receptors, Angiotensin; Tumor Cells, Cultured	1992
A newly found angiotensin II receptor subtype mediates cyclic GMP formation in differentiated Neuro-2A cells. European journal of pharmacology, 1992, Apr-10, Volume: 225, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Binding Sites; Biphenyl Compounds; Cell Differentiation; Cyclic GMP; Imidazoles; Losartan; Neuroblastoma; Pyridines; Receptors, Angiotensin; Tetrazoles; Tumor Cells, Cultured	1992
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis. Journal of hepatology, 1992, Volume: 15, Issue:1-2 Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Renin; Sodium; Spironolactone	1992
Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:1 Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cattle; Cyclic GMP; Polysaccharides	1992
Characterization of biochemical responses of angiotensin II (AT2) binding sites in the rat pheochromocytoma PC12W cells. European journal of pharmacology, 1992, Sep-01, Volume: 227, Issue:1 Topics: Angiotensin II; Animals; Arachidonic Acid; Binding Sites; Calcium; Cell Membrane; Cyclic AMP; Cyclic GMP; DNA; Epoprostenol; Iodine Radioisotopes; Radioligand Assay; Rats; Tumor Cells, Cultured	1992
Phosphoinositide and calcium signalling responses in smooth muscle cells: comparison between lipoproteins, Ang II, and PDGF. Biochemical and biophysical research communications, 1992, Nov-16, Volume: 188, Issue:3 Topics: Angiotensin II; Calcium; Colforsin; Cyclic GMP; Cytosol; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Muscle, Smooth, Vascular; Phosphatidylinositols; Platelet-Derived Growth Factor; Second Messenger Systems; Tetradecanoylphorbol Acetate	1992
Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney international, 1992, Volume: 42, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Endothelins; Glomerular Mesangium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Nitroprusside; Protein Kinase C; Rats; Rats, Sprague-Dawley	1992
Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells. Journal of the American Society of Nephrology : JASN, 1992, Volume: 3, Issue:5 Topics: Actin Cytoskeleton; Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cytochalasin B; Cytoskeleton; Epithelium; Kidney Glomerulus; Male; Microscopy, Fluorescence; Microtubules; Nitroprusside; Rats; Rats, Sprague-Dawley; Second Messenger Systems; Tubulin	1992
Angiotensin II-induced proliferation of cultured murine mesangial cells: inhibitory role of atrial natriuretic peptide. Journal of the American Society of Nephrology : JASN, 1992, Volume: 3, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Base Sequence; Cell Division; Cell Line; Cyclic GMP; DNA; Gene Expression; Glomerular Mesangium; Mice; Molecular Sequence Data; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Receptors, Angiotensin	1992
Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. European journal of biochemistry, 1992, Jan-15, Volume: 203, Issue:1-2 Topics: Amino Acid Oxidoreductases; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Enzyme Induction; Glomerular Mesangium; Interleukin-1; Macrophages; Nitric Oxide Synthase; Rats; Tumor Necrosis Factor-alpha	1992
Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. The Journal of clinical investigation, 1991, Volume: 87, Issue:6 Topics: Angiotensin II; Atrial Natriuretic Factor; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclic GMP; Endothelins; Endothelium, Vascular; Humans; Immunoassay; In Vitro Techniques; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Secretory Rate; Thrombin	1991
Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system. The American journal of physiology, 1991, Volume: 260, Issue:6 Pt 2 Topics: Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Circadian Rhythm; Cyclic GMP; Dinoprostone; Female; Glomerular Filtration Rate; Heart Rate; Humans; Male; Middle Aged; Myocardium; Potassium; Renal Circulation; Renin; Renin-Angiotensin System; Sodium; Urinary Retention	1991
Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1991, Volume: 6, Issue:6 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Body Water; Cyclic GMP; Dinoprostone; Female; Furosemide; Humans; Male; Middle Aged; Nephrotic Syndrome; Sodium	1991
Selective inhibition of cGMP-inhibitable cAMP phosphodiesterase decreases pulmonary vasoreactivity. The American journal of physiology, 1991, Volume: 261, Issue:2 Pt 2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Angiotensin II; Animals; Blood; Blood Pressure; Cyclic GMP; Hypoxia; In Vitro Techniques; Male; Perfusion; Phosphodiesterase Inhibitors; Pulmonary Circulation; Rats; Vasoconstriction	1991
Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. The Journal of clinical investigation, 1991, Volume: 88, Issue:5 Topics: Alanine; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Neprilysin; Sodium	1991
Downregulation of glomerular and vascular atrial natriuretic factor receptor subtypes by angiotensin II. Journal of hypertension, 1991, Volume: 9, Issue:12 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Down-Regulation; Kidney Glomerulus; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	1991
Vascular effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, in isolated rat arteries. Japanese journal of pharmacology, 1991, Volume: 55, Issue:3 Topics: Adrenergic beta-Antagonists; Angiotensin II; Animals; Arteries; Betaxolol; Calcitonin Gene-Related Peptide; Calcium; Cyclic GMP; Cytosol; Heart; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium; Potassium Channels; Prostaglandins; Rats; Rats, Inbred Strains; Serotonin	1991
Angiotensin II and atrial natriuretic factor receptor interactions at the blood-brain barrier. Brain research, 1991, Oct-18, Volume: 562, Issue:1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood-Brain Barrier; Cerebrovascular Circulation; Cyclic GMP; Diglycerides; Guanylate Cyclase; In Vitro Techniques; Kinetics; Microcirculation; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	1991
Atrial natriuretic factor alters phospholipid metabolism in mesangial cells. The American journal of physiology, 1990, Volume: 258, Issue:1 Pt 1 Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Arachidonic Acid; Arachidonic Acids; Atrial Natriuretic Factor; Calcimycin; Calcium; Cells, Cultured; Cyclic GMP; Glomerular Mesangium; Inositol; Inositol Phosphates; Kinetics; Male; Muscle, Smooth; Nitroprusside; Phosphatidylinositols; Phospholipids; Rats; Rats, Inbred Strains	1990
Angiotensin II decreases cGMP levels in neuronal cultures from rat brain. The American journal of physiology, 1991, Volume: 260, Issue:1 Pt 1 Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Animals, Newborn; Astrocytes; Brain Stem; Cadmium; Cadmium Chloride; Cells, Cultured; Cyclic GMP; Hypothalamus; Kinetics; Neurons; Nitroprusside; Rats; Rats, Inbred Strains; Receptors, Angiotensin	1991
Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Kidney international, 1991, Volume: 40, Issue:2 Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Glomerular Mesangium; Guanylate Cyclase; Isoquinolines; Kinetics; Piperazines; Protein Kinase C; Tetradecanoylphorbol Acetate	1991
Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells. The American journal of physiology, 1991, Volume: 260, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Autoradiography; Cell Membrane; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endothelins; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Signal Transduction; Time Factors	1991
Guanabenz-induced inhibition of aldosterone secretion from isolated rat adrenal glomerulosa cells. The American journal of the medical sciences, 1991, Volume: 301, Issue:1 Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Bucladesine; Cyclic GMP; Female; Guanabenz; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Secretory Rate; Zona Glomerulosa	1991
Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril. Proceedings of the National Academy of Sciences of the United States of America, 1991, May-15, Volume: 88, Issue:10 Topics: Alanine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cell Membrane; Cyclic GMP; Dioxoles; Dipeptides; Diuresis; Glycine; Humans; Lung; Male; Mice; Molecular Structure; Natriuresis; Neprilysin; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Strains; Thiorphan	1991
[Sodium nitroprusside and inhibition of coronary vasoconstriction in isolated hearts of guinea pigs]. Cardiologia (Rome, Italy), 1990, Volume: 35, Issue:10 Topics: Angiotensin II; Animals; Coronary Vessels; Cyclic GMP; Female; Guinea Pigs; Hydrolysis; In Vitro Techniques; Male; Nitroprusside; Phosphatidylinositols; Vasoconstriction	1990
Effects of endothelin-1 on the isolated guinea-pig ileum: role of Na+ ions. Naunyn-Schmiedeberg's archives of pharmacology, 1990, Volume: 342, Issue:6 Topics: Angiotensin II; Animals; Cyclic GMP; Drug Administration Schedule; Endothelins; Female; Guinea Pigs; Ileum; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Ouabain; Sodium; Verapamil	1990
Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1990, Volume: 5, Issue:12 Topics: Adult; Albumins; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Female; Furosemide; Glomerulonephritis; Humans; Male; Middle Aged; Natriuresis	1990
Effects of atrial natriuretic factor on angiotensin-II-and phorbol ester-stimulated protein kinase-C and prostacyclin production in cultured rat aortic smooth muscle cells. Endocrinology, 1990, Volume: 126, Issue:1 Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Epoprostenol; Muscle, Smooth, Vascular; Protein Kinase C; Rats; Tetradecanoylphorbol Acetate	1990
Effect of atrial natriuretic peptide on blood pressure, guanosine 3':5'-cyclic monophosphate release and blood volume in uraemic patients. Clinical science (London, England : 1979), 1990, Volume: 78, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Cyclic GMP; Female; Heart Rate; Humans; Male; Middle Aged; Uremia	1990
Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. The American journal of physiology, 1990, Volume: 258, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Bradykinin; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Glomerular Mesangium; Hemoglobins; Nitric Oxide; Rats; Superoxide Dismutase	1990
[Angiotensin II decreases atrial natriuretic peptide-induced cyclic GMP accumulation in rat glomerular mesangial cells]. Nihon Jinzo Gakkai shi, 1990, Volume: 32, Issue:2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Depression, Chemical; Glomerular Mesangium; Male; Rats; Rats, Inbred Strains	1990
Characteristics of atrial natriuretic hormone receptors in human pheochromocytomas. Acta endocrinologica, 1990, Volume: 122, Issue:6 Topics: Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Binding, Competitive; Chromatography, Ion Exchange; Cyclic GMP; Desoxycorticosterone; Dopamine; Humans; Neuropeptide Y; Pheochromocytoma; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Vasopressins	1990
Attenuated glomerular responses to atrial natriuretic factor in low-sodium rats is prevented by theophylline. Biochemical and biophysical research communications, 1990, Jul-31, Volume: 170, Issue:2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cyclic GMP; Glomerular Filtration Rate; Kidney Glomerulus; Male; Phosphodiesterase I; Phosphoric Diester Hydrolases; Rats; Rats, Inbred Strains; Sodium; Theophylline	1990
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. The Journal of clinical investigation, 1990, Volume: 86, Issue:5 Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cell Division; Cell Line; Cyclic GMP; Down-Regulation; Hypertrophy; Muscle, Smooth, Vascular; Protein Kinase C; Rats; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Transforming Growth Factor beta	1990
Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction. Inflammation, 1990, Volume: 14, Issue:5 Topics: Angiotensin II; Animals; Bradykinin; Calcium; Capillary Permeability; Cattle; Cells, Cultured; Cyclic GMP; Edetic Acid; Endothelium, Vascular; Epoprostenol; Gallic Acid; Indomethacin; Intercellular Junctions; Isoproterenol; Myosin-Light-Chain Kinase; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Pulmonary Edema; Second Messenger Systems; Tetradecanoylphorbol Acetate; Thrombin; Trifluoperazine	1990
Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction. Lung, 1990, Volume: 168, Issue:6 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Cyclic GMP; Dose-Response Relationship, Drug; Hypoxia; Lung; Male; Meclofenamic Acid; Purinones; Rats; Vasoconstriction	1990
Ca2+-dependent modulation of renin release from isolated glomeruli: apparent independence from alterations in cGMP. Metabolism: clinical and experimental, 1985, Volume: 34, Issue:7 Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Calcium; Calmodulin; Cyclic GMP; Female; In Vitro Techniques; Isoproterenol; Kidney Glomerulus; Nitroprusside; Ouabain; Potassium Chloride; Rats; Rats, Inbred Strains; Renin	1985
Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. The American journal of physiology, 1987, Volume: 253, Issue:1 Pt 1 Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Muscle, Smooth, Vascular; Nitroprusside	1987
Methylene blue selectively inhibits pulmonary vasodilator responses in cats. Journal of applied physiology (Bethesda, Md. : 1985), 1989, Volume: 66, Issue:3 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Acetylcholine; Angiotensin II; Animals; Blood Pressure; Bradykinin; Cats; Cyclic GMP; Epinephrine; Female; Isoproterenol; Male; Methylene Blue; Nitroglycerin; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Pulmonary Circulation; Reference Values; Vasodilation	1989
Atrial natriuretic peptide decreases contractility of cultured chick ventricular cells. Life sciences, 1989, Volume: 45, Issue:1 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Calcium Channels; Cells, Cultured; Chick Embryo; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Heart; Heart Ventricles; Isoproterenol; Myocardial Contraction	1989
Atrial natriuretic factor inhibits angiotensin-induced aldosterone secretion: not through cGMP or interference with phospholipase C. Biochemical and biophysical research communications, 1989, Feb-28, Volume: 159, Issue:1 Topics: Aldosterone; Aminoquinolines; Angiotensin II; Animals; Atrial Natriuretic Factor; Calcium; Cattle; Cyclic GMP; Cytosol; Fluorescent Dyes; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Phosphoproteins; Phosphorylation; Type C Phospholipases; Zona Glomerulosa	1989
Angiotensin II induces oscillations of intracellular calcium and blocks anomalous inward rectifying potassium current in mouse renal juxtaglomerular cells. Proceedings of the National Academy of Sciences of the United States of America, 1989, Volume: 86, Issue:9 Topics: Angiotensin II; Animals; Calcium; Chloride Channels; Chlorides; Cyclic AMP; Cyclic GMP; Electric Conductivity; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Juxtaglomerular Apparatus; Kinetics; Membrane Potentials; Membrane Proteins; Mice; Potassium Channels; Thionucleotides	1989
Modulation of renin synthesis by lipoxygenase products in cultured human mesangial cells. Molecular and cellular endocrinology, 1989, Volume: 62, Issue:2 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Calcium; Cyclic AMP; Cyclic GMP; Diglycerides; Dinoprostone; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Kidney Cortex; Leukotrienes; Lipid Peroxides; Lipoxygenase; Renin	1989
Atrial natriuretic peptide and nitroprusside cause relaxation of cultured rat mesangial cells. The American journal of physiology, 1989, Volume: 257, Issue:1 Pt 1 Topics: Amanitins; Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Dibutyryl Cyclic GMP; Ferricyanides; Fluorescent Dyes; Glomerular Mesangium; Methylene Blue; Microscopy, Fluorescence; Nitroprusside; Rats	1989
Vasoconstrictor-induced heterologous down-regulation of vascular atrial natriuretic peptide receptor. European journal of pharmacology, 1989, May-30, Volume: 164, Issue:3 Topics: Angiotensin II; Animals; Arginine Vasopressin; Cyclic GMP; Humans; In Vitro Techniques; Iodine Radioisotopes; Muscle, Smooth, Vascular; Piperidines; Rats; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents	1989
Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes. Biochemical and biophysical research communications, 1989, Sep-29, Volume: 163, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Drug Interactions; Heart; Heart Ventricles; In Vitro Techniques; Kinetics; Myocardial Contraction; Rats; Rats, Inbred Strains; Ventricular Function	1989
[Homologous and heterologous regulation of atrial natriuretic factor receptors in smooth muscle cells]. Archives des maladies du coeur et des vaisseaux, 1989, Volume: 82, Issue:7 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Male; Muscle, Smooth; Rats; Rats, Inbred Strains; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	1989
Inhibition of Jv by ANF in rat proximal straight tubules requires angiotensin. The American journal of physiology, 1989, Volume: 257, Issue:5 Pt 2 Topics: Absorption; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Dibutyryl Cyclic GMP; Kidney Tubules, Proximal; Osmolar Concentration; Rats; Rats, Inbred Strains; Second Messenger Systems	1989
Neuroendocrine response in acute heart failure and the influence of treatment. European heart journal, 1989, Volume: 10, Issue:12 Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Cyclic GMP; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents	1989
Effect of several vasoactive agents on guanylate cyclase activity in isolated rat brain microvessels. Neuroscience letters, 1989, Dec-15, Volume: 107, Issue:1-3 Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Vessels; Brain; Cyclic GMP; Guanylate Cyclase; In Vitro Techniques; Male; Rats; Rats, Inbred Strains	1989
Bovine adrenal medullary cells contain functional atrial natriuretic peptide receptors. Biochemical and biophysical research communications, 1988, Jan-29, Volume: 150, Issue:2 Topics: Adrenal Cortex; Adrenal Medulla; Amiloride; Angiotensin II; Animals; Atrial Natriuretic Factor; Binding, Competitive; Carbachol; Cattle; Cell Membrane; Cyclic GMP; Kinetics; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	1988
The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion. Endocrinology, 1988, Volume: 122, Issue:3 Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Carbachol; Cattle; Colforsin; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Kinetics; Pertussis Toxin; Virulence Factors, Bordetella	1988
Effect of atrial natriuretic peptide on renin release in a superfusion system of kidney slices and dispersed juxtaglomerular cells. Endocrinology, 1988, Volume: 122, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Female; Isoproterenol; Juxtaglomerular Apparatus; Kidney Cortex; Perfusion; Rats; Rats, Inbred Strains; Renin	1988
Regulation of angiotensin II receptors in cultured rat ovarian granulosa cells by follicle-stimulating hormone and angiotensin II. The Journal of biological chemistry, 1988, Aug-25, Volume: 263, Issue:24 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Animals; Aromatase; Calcimycin; Cells, Cultured; Cyclic GMP; Estradiol; Female; Follicle Stimulating Hormone; Granulosa Cells; Kinetics; Progesterone; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Testosterone; Tetradecanoylphorbol Acetate	1988
Porcine brain natriuretic peptide, another modulator of bovine adrenocortical steroidogenesis. FEBS letters, 1988, Aug-29, Volume: 236, Issue:2 Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Cattle; Cell Membrane; Cyclic GMP; Hydrocortisone; In Vitro Techniques; Kinetics; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	1988
Angiotensin II-induced relaxation of fowl aorta. The American journal of physiology, 1988, Volume: 255, Issue:4 Pt 2 Topics: 5,8,11,14-Eicosatetraynoic Acid; Angiotensin II; Animals; Aorta, Abdominal; Chickens; Cimetidine; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Indomethacin; Methysergide; Microscopy, Electron; Muscle, Smooth, Vascular; Ouabain; Proadifen; Propranolol; Pyrilamine; Vasodilation	1988
Regulation of phosphorylase A formation and calcium content in aortic smooth muscle and smooth muscle cells: effects of atrial natriuretic peptide II. The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2 Topics: Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Benzofurans; Calcium; Cells, Cultured; Colforsin; Cyclic GMP; Fura-2; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Norepinephrine; Phosphorylase a; Phosphorylases; Potassium Chloride; Rats; Rats, Inbred Strains	1988
Effects of alpha-human atrial natriuretic polypeptide, sodium nitroprusside and dibutyryl cyclic GMP on aldosterone production in bovine zona glomerulosa cells. Acta endocrinologica, 1988, Volume: 119, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cattle; Cyclic GMP; Dibutyryl Cyclic GMP; Ferricyanides; Nitroprusside; Zona Glomerulosa	1988
Cyclic AMP and cyclic GMP in hyperresponsiveness. Life sciences, 1988, Volume: 43, Issue:24 Topics: Angiotensin II; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Male; Norepinephrine; Rats; Reference Values	1988
Interaction between atrial natriuretic factor and angiotensin II receptors in the regulation of blood pressure. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1988, Volume: 6, Issue:4 Topics: Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Enzyme Activation; In Vitro Techniques; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	1988
Atrial natriuretic factor induced phosphorylation of human placental membrane protein: an effect mimicked by guanosine 3':5'-cyclic monophosphate. Biochemical and biophysical research communications, 1986, Sep-14, Volume: 139, Issue:2 Topics: Angiotensin II; Atrial Natriuretic Factor; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Guanylate Cyclase; Humans; Membrane Proteins; Phosphorylation; Placenta; Protein Kinases	1986
Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth-muscle cells. European journal of biochemistry, 1988, Mar-01, Volume: 172, Issue:2 Topics: Angiotensin II; Animals; Aorta, Thoracic; Arachidonic Acid; Arachidonic Acids; Atrial Natriuretic Factor; Binding Sites; Cells, Cultured; Cyclic AMP; Cyclic GMP; Enzyme Activation; Guanylate Cyclase; Humans; Muscle, Smooth, Vascular; Phosphatidylinositols; Rats	1988
Hormonal control of polyamine levels in bovine adrenocortical cells. Endocrinology, 1986, Volume: 118, Issue:3 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex; Adrenocorticotropic Hormone; Amino Acids; Angiotensin II; Animals; Biological Transport; Cattle; Cells, Cultured; Cyclic GMP; Enzyme Induction; Ornithine Decarboxylase; Polyamines; Tetradecanoylphorbol Acetate	1986
[A study on the pathophysiologic changes in different types of patients with essential hypertension based on traditional Chinese medical classification]. Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, 1985, Volume: 5, Issue:11 Topics: Adult; Aged; Angiotensin II; Cyclic AMP; Cyclic GMP; Female; Humans; Hypertension; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Middle Aged; Renin	1985
Atrial natriuretic peptide elevates cGMP contents in glomeruli and in distal tubules of rat kidney. Biochemical and biophysical research communications, 1986, May-14, Volume: 136, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Atropine; Carbachol; Cyclic GMP; Kidney Glomerulus; Kidney Tubules; Kidney Tubules, Distal; Male; Norepinephrine; Rats; Rats, Inbred Strains	1986
Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin. European journal of pharmacology, 1986, Jul-15, Volume: 126, Issue:1-2 Topics: Angiotensin II; Animals; Bradykinin; Cells, Cultured; Cyclic GMP; Lithium; Mice; Neurotensin; Phosphodiesterase Inhibitors	1986
Synthetic atrial natriuretic factors (ANFs) stimulate guanine 3',5'-monophosphate production but not hormone release in rat pituitary cells: peptide contamination with a gonadotropin-releasing hormone agonist explains luteinizing hormone-releasing activit Endocrinology, 1987, Volume: 120, Issue:1 Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic AMP; Cyclic GMP; Gonadotropin-Releasing Hormone; Hormones; Luteinizing Hormone; Pituitary Gland, Anterior; Pituitary Hormones, Anterior; Rats; Secretory Rate	1987
Early agonist-mediated ionic events in cultured vascular smooth muscle cells. Calcium mobilization is associated with intracellular acidification. The Journal of biological chemistry, 1987, Apr-15, Volume: 262, Issue:11 Topics: Amiloride; Aminoquinolines; Angiotensin II; Animals; Calcium; Calcium-Transporting ATPases; Carrier Proteins; Cyclic GMP; Hydrogen-Ion Concentration; Intracellular Fluid; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Sodium; Sodium-Hydrogen Exchangers; Tetradecanoylphorbol Acetate	1987
Angiotensin II stimulation of vascular smooth muscle phosphoinositide metabolism. State of the art lecture. Hypertension (Dallas, Tex. : 1979), 1987, Volume: 9, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Biomechanical Phenomena; Calcium; Cyclic GMP; Hydrogen-Ion Concentration; Hydrolysis; Intracellular Membranes; Muscle, Smooth, Vascular; Phosphatidylinositols; Protein Kinase C; Rats; Receptors, Angiotensin; Stimulation, Chemical	1987
Effects of 8-bromo-cGMP on Ca2+ levels in vascular smooth muscle cells: possible regulation of Ca2+-ATPase by cGMP-dependent protein kinase. Proceedings of the National Academy of Sciences of the United States of America, 1987, Volume: 84, Issue:16 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Benzofurans; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Cyclic GMP; Fluorometry; Fura-2; Muscle, Smooth, Vascular; Phosphorylation; Protein Kinases; Rats	1987
Mechanism of action of some bronchodilators. Cyclic nucleotide metabolism in tracheal preparations. The American review of respiratory disease, 1974, Volume: 110, Issue:6 Pt 2 Topics: Adrenocorticotropic Hormone; Angiotensin II; Animals; Atropine; Bronchodilator Agents; Carbachol; Choline; Cyclic AMP; Cyclic GMP; Diphenhydramine; Dose-Response Relationship, Drug; Epinephrine; Glucagon; Guinea Pigs; Histamine; In Vitro Techniques; Isoproterenol; Phenoxybenzamine; Phenylephrine; Practolol; Propranolol; Prostaglandins; Serotonin; Theophylline; Time Factors; Trachea	1974
[Influence of various hormones on formation of adenosine-3':5'-monophosphate and guanosine-3':5'-monophosphate by particulate preparations from rat kidney]. European journal of biochemistry, 1972, Jan-21, Volume: 24, Issue:3 Topics: Adenosine Triphosphate; Adenylyl Cyclases; Angiotensin II; Animals; Calcitonin; Cell Membrane; Cyclic AMP; Cyclic GMP; Diabetes Insipidus; Guanosine Triphosphate; Hormones; Isoproterenol; Kidney; Kidney Tubules; Magnesium; Male; Norepinephrine; Oxytocin; Parathyroid Hormone; Prostaglandins; Rats; Vasopressins; Water	1972
Effects of bradykinin and indomethacin on cyclic GMP and cyclic AMP in lung slices. Proceedings of the National Academy of Sciences of the United States of America, 1973, Volume: 70, Issue:12 Topics: Acetylcholine; Angiotensin II; Animals; Aspirin; Bradykinin; Culture Techniques; Cyclic AMP; Cyclic GMP; Guinea Pigs; Histamine; Indomethacin; Isoproterenol; Lung; Peptides; Promethazine; Stimulation, Chemical; Theophylline	1973
Cyclic nucleotide levels in incubations of guinea pig trachea. Biochimica et biophysica acta, 1974, Apr-22, Volume: 343, Issue:2 Topics: Acetylcholine; Adrenocorticotropic Hormone; Angiotensin II; Animals; Atropine; Carbachol; Cyclic AMP; Cyclic GMP; Epinephrine; Glucagon; Histamine; Iodine Radioisotopes; Muscle, Smooth; Phenoxybenzamine; Phenylephrine; Propranolol; Prostaglandins; Radioimmunoassay; Serotonin; Theophylline; Trachea; Tritium	1974
The effect of angiotensins I, II, and III on formation of cyclic GMP in murine neuroblastoma clone N1E-115. Biochemical pharmacology, 1984, Aug-01, Volume: 33, Issue:15 Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensins; Animals; Clone Cells; Cyclic GMP; Mice; Neuroblastoma; Neurons; Receptors, Angiotensin	1984
Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and arginine vasopressin. The Journal of clinical investigation, 1980, Volume: 65, Issue:3 Topics: 1-Methyl-3-isobutylxanthine; Angiotensin II; Animals; Arginine Vasopressin; Cells, Cultured; Cyclic AMP; Cyclic GMP; Kidney Glomerulus; Lypressin; Muscle Contraction; Parathyroid Hormone; Prostaglandins E, Synthetic; Rats	1980
The glomerulus: site of synthesis and target for hormones and chemical mediators. Advances in nephrology from the Necker Hospital, 1981, Volume: 10 Topics: Angiotensin II; Animals; Calcium; Cyclic AMP; Cyclic GMP; Fibrinolysis; Histamine; In Vitro Techniques; Kidney Glomerulus; Parathyroid Hormone; Prostaglandins; Rats; Receptors, Angiotensin; Receptors, Cell Surface; Serotonin	1981
The primary tissue culture of human adrenocortical Conn's adenomata. I. The synergistic stimulation of adenomatous cell growth by purine cyclic nucleotides and by ACTH1-24 and angiotensin II. Pathology, research and practice, 1981, Volume: 173, Issue:1-2 Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Angiotensin II; Cell Division; Cosyntropin; Culture Techniques; Cyclic AMP; Cyclic GMP; Humans; Hyperaldosteronism; Time Factors	1981
Angiotensin AT2 receptor mediated inhibition of particulate guanylate cyclase: a link with protein tyrosine phosphatase stimulation? Receptors & channels, 1994, Volume: 2, Issue:2 Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Aorta; Arsenicals; Atrial Natriuretic Factor; Cell Membrane; Cells, Cultured; Cyclic GMP; GTP-Binding Proteins; Guanylate Cyclase; Muscle, Smooth, Vascular; Oligopeptides; PC12 Cells; Protein Tyrosine Phosphatases; Rats; Receptors, Angiotensin; Vanadates	1994
Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. European journal of pharmacology, 1995, Jan-16, Volume: 288, Issue:2 Topics: Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Bucladesine; Cyclic GMP; Down-Regulation; Extracellular Space; In Vitro Techniques; Isosorbide Dinitrate; Lipopolysaccharides; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Nitroprusside; Penicillamine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents	1995
Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites. Scandinavian journal of clinical and laboratory investigation, 1995, Volume: 55, Issue:4 Topics: Adult; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Ascites; Atrial Natriuretic Factor; Cyclic GMP; Dinoprostone; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Renal Plasma Flow, Effective; Sodium; Urination	1995
Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arteriosclerosis, thrombosis, and vascular biology, 1995, Volume: 15, Issue:10 Topics: Angiotensin II; Animals; Carotid Arteries; Cyclic GMP; Endothelium, Vascular; In Vitro Techniques; Rats; Rats, Inbred WKY; Receptors, Angiotensin; Vasodilation	1995
Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products. Cardiovascular research, 1995, Volume: 30, Issue:2 Topics: Angiotensin II; Animals; Arginine; Arteries; Blood Pressure; Coronary Vessels; Cyclic GMP; Cyclooxygenase Inhibitors; Dinoprostone; Dogs; Indomethacin; Lymph; Male; Metabolic Clearance Rate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proteins; Vasoconstrictor Agents	1995
Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:5 Topics: Angiotensin II; Animals; Carotid Arteries; Cyclic GMP; Endothelium, Vascular; Muscle, Smooth, Vascular; Nitric Oxide; Rats; Rats, Inbred WKY; Receptors, Angiotensin; Vasoconstriction	1995
Glomerular and tubular interactions between renal adrenergic activity and nitric oxide. The American journal of physiology, 1995, Volume: 268, Issue:6 Pt 2 Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Capillaries; Cyclic GMP; Denervation; Glomerular Filtration Rate; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Models, Biological; Models, Theoretical; Nephrons; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Wistar; Renal Circulation	1995
Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. The Journal of clinical investigation, 1995, Volume: 96, Issue:2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; DNA, Complementary; Endothelins; Fibroblasts; Myocardium; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Nitroprusside; Rats	1995
Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats. Journal of hypertension, 1995, Volume: 13, Issue:1 Topics: Angiotensin II; Animals; Cyclic AMP; Cyclic GMP; Eicosanoids; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Hemodynamics; Hypertension; Injections, Subcutaneous; Kidney; Lipid Peroxides; Radioimmunoassay; Rats	1995
A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. The Journal of biological chemistry, 1995, Jan-27, Volume: 270, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium Channels; Cyclic GMP; Glioma; GTP-Binding Proteins; Hybrid Cells; Kinetics; Membrane Potentials; Neuroblastoma; Oligopeptides; Patch-Clamp Techniques; Receptors, Angiotensin; Time Factors	1995
Biological actions and pharmacokinetics of C-type natriuretic peptide in conscious sheep. The American journal of physiology, 1995, Volume: 268, Issue:1 Pt 2 Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Consciousness; Creatinine; Cyclic GMP; Dose-Response Relationship, Drug; Female; Heart Rate; Hemodynamics; Hormones; Hydrocortisone; Infusions, Intravenous; Kidney; Metabolic Clearance Rate; Natriuretic Peptide, C-Type; Potassium; Proteins; Pulmonary Circulation; Sheep; Sodium; Time Factors; Vascular Resistance	1995
cGMP antagonizes angiotensin-mediated phosphatidylcholine hydrolysis and C kinase activation in mesangial cells. The American journal of physiology, 1995, Volume: 268, Issue:2 Pt 1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Diglycerides; Enzyme Activation; Glomerular Mesangium; Hydrolysis; Male; Nitroprusside; Phosphatidylcholines; Phospholipase D; Protein Kinase C; Rats; Rats, Sprague-Dawley	1995
Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans. The American journal of physiology, 1993, Volume: 264, Issue:2 Pt 2 Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hand; Humans; Labetalol; Male; Methylene Blue; Nitric Oxide; Skin; Vasoconstriction; Veins	1993
Effects of atrial natriuretic factor on cyclic nucleotides in rabbit proximal tubule. Hypertension (Dallas, Tex. : 1979), 1994, Volume: 23, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic AMP; Cyclic GMP; Kidney Tubules, Proximal; Rabbits; Signal Transduction; Suspensions	1994
Identification of AT2 angiotensin receptors on Swiss 3T3 cells. Biochemistry and molecular biology international, 1993, Volume: 31, Issue:5 Topics: 3T3 Cells; Angiotensin II; Animals; Binding Sites; Bombesin; Calcium; Cyclic GMP; DNA; Electrophoresis, Polyacrylamide Gel; Growth Substances; Hydrolysis; Mice; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein Kinase C; Receptors, Angiotensin; Signal Transduction	1993
The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Bradykinin; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Female; In Vitro Techniques; Male; Myocardial Ischemia; Nitric Oxide; Nitroarginine; Oligopeptides; Rats; Rats, Wistar; Receptors, Angiotensin	1993
Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1 Topics: Angiotensin II; Animals; Arterioles; Cattle; Cell Count; Cell Division; Cells, Cultured; Cyclic GMP; DNA; Kidney; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide; Penicillamine; Rats; S-Nitroso-N-Acetylpenicillamine; Vasodilator Agents	1994
Unchanged noradrenaline reactivity and blood pressure after corrective surgery in primary hyperparathyroidism. Scandinavian journal of clinical and laboratory investigation, 1993, Volume: 53, Issue:5 Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Calcium; Cyclic GMP; Dinoprostone; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Norepinephrine; Sodium	1993
Influence of sodium and potassium diets on adrenal vasopressin content and direct effects of vasopressin on aldosterone synthesis in adrenocortical cells. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1993, Volume: 25, Issue:8 Topics: Adrenal Cortex; Adrenal Glands; Aldosterone; Angiotensin II; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Cell Membrane; Cyclic GMP; Female; In Vitro Techniques; Iodine Radioisotopes; Male; Potassium, Dietary; Rats; Rats, Wistar; Receptors, Vasopressin; Sodium, Dietary; Zona Glomerulosa	1993
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate. Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:5 Topics: Aging; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Indoles; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Pregnancy; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Systole	1993
Alteration of mesangial response to ANP and angiotensin II by glucose. Kidney international, 1993, Volume: 44, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Glomerular Mesangium; Glucose; Inositol 1,4,5-Trisphosphate; Rats	1993
Prejunctional receptors and second messengers for angiotensin II in the rabbit iris-ciliary body. Experimental eye research, 1993, Volume: 57, Issue:4 Topics: Angiotensin II; Animals; Ciliary Body; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Female; Iris; Male; Norepinephrine; Phosphatidylinositols; Rabbits; Receptors, Angiotensin; Saralasin; Second Messenger Systems; Signal Transduction; Stimulation, Chemical	1993
Down-regulation of angiotensin II receptor subtypes and desensitization of cyclic GMP production in neuroblastoma N1E-115 cells. Journal of neurochemistry, 1993, Volume: 60, Issue:1 Topics: Angiotensin II; Animals; Cyclic GMP; Down-Regulation; Mice; Neuroblastoma; Receptors, Angiotensin; Time Factors; Tumor Cells, Cultured	1993
Angiotensin II type 2 receptor expression in neuronal cultures from spontaneously hypertensive rat brain. Regulatory peptides, 1993, Mar-19, Volume: 44, Issue:2 Topics: Angiotensin II; Animals; Brain Stem; Cells, Cultured; Cyclic GMP; Hypertension; Hypothalamus; Neurons; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Tumor Cells, Cultured	1993
Agonistic and antagonistic properties of angiotensin analogs at the AT2 receptor in PC12W cells. Regulatory peptides, 1993, Mar-19, Volume: 44, Issue:2 Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Biphenyl Compounds; Cyclic GMP; Imidazoles; Losartan; Oligopeptides; PC12 Cells; Pyridines; Rats; Receptors, Angiotensin; Tetrazoles	1993
Effects of atrial natriuretic peptide and cGMP on uptake of IgG complexes by macrophages. The American journal of physiology, 1993, Volume: 265, Issue:1 Pt 1 Topics: Angiotensin II; Atrial Natriuretic Factor; Bucladesine; Cell Line; Cyclic GMP; Gold; Immunoglobulin G; Macrophages; Nitroprusside	1993
Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells. The Journal of clinical investigation, 1993, Volume: 92, Issue:3 Topics: Angiotensin II; Animals; Arginine; Calcium; Cells, Cultured; Cyclic GMP; In Vitro Techniques; Inositol 1,4,5-Trisphosphate; Insulin; Male; Muscle, Smooth, Vascular; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin	1993
Pulmonary hypertension. Response of vasoactive peptides to a nonionic contrast medium in patients undergoing pulmonary angiography. Investigative radiology, 1995, Volume: 30, Issue:9 Topics: Adult; Aged; Aldosterone; Anaphylaxis; Angiography, Digital Subtraction; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Proteins; Chymases; Contrast Media; Cyclic GMP; Electrocardiography; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Female; Heart Rate; Humans; Hypertension, Pulmonary; Inflammation Mediators; Iohexol; Lung; Male; Middle Aged; Myoglobin; Peptides; Peptidyl-Dipeptidase A; Renin; Ribonucleases; Serine Endopeptidases; Tryptases; Vasopressins	1995
Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate. Nephron, 1995, Volume: 71, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Body Water; Case-Control Studies; Cyclic GMP; Dinoprostone; Endothelins; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Nephrotic Syndrome; Renal Plasma Flow; Sodium	1995
Effect of endotoxin on the angiotensin II receptor in cultured vascular smooth muscle cells. British journal of pharmacology, 1995, Volume: 116, Issue:5 Topics: Angiotensin II; Animals; Blotting, Northern; Cells, Cultured; Cyclic GMP; Endotoxins; Escherichia coli; Inositol Phosphates; Lipopolysaccharides; Muscle, Smooth, Vascular; Radioligand Assay; Rats; Receptors, Angiotensin; Receptors, Vasopressin; RNA; Stimulation, Chemical	1995
Unilateral ureteral obstruction increases glomerular soluble guanylyl cyclase activity. Journal of the American Society of Nephrology : JASN, 1995, Volume: 6, Issue:5 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Cyclic GMP; Imidazoles; Kidney Glomerulus; Losartan; Male; Nitroprusside; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; Tetrazoles; Ureteral Obstruction; Vasoconstrictor Agents	1995
Natriuretic peptides increase a K+ conductance in rat mesangial cells. Pflugers Archiv : European journal of physiology, 1996, Volume: 431, Issue:4 Topics: Adenosine; Angiotensin II; Animals; Atrial Natriuretic Factor; Brain Chemistry; Cells, Cultured; Cyclic GMP; Electric Conductivity; Glomerular Mesangium; Membrane Potentials; Muscle Proteins; Patch-Clamp Techniques; Potassium Channels; Rats; Rats, Inbred WKY; Vasodilator Agents	1996
Chronic ouabain infusion does not cause hypertension in sheep. The American journal of physiology, 1996, Volume: 270, Issue:3 Pt 1 Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension; Infusions, Intravenous; Ouabain; Potassium; Pulse; Rats; Renin; Renin-Angiotensin System; Sheep; Sodium; Time Factors	1996
Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 27, Issue:6 Topics: Alanine; Angiotensin II; Animals; Aorta, Abdominal; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; Enzyme Inhibitors; Heart Failure; Hemodynamics; Male; Natriuresis; Neprilysin; Rats; Rats, Wistar; Renin; Vena Cava, Inferior	1996
Angiotensin II receptor subtypes and phosphoinositide hydrolysis in rat adrenal medulla. Brain research bulletin, 1995, Volume: 38, Issue:5 Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Biphenyl Compounds; Cyclic GMP; Hydrolysis; Imidazoles; Losartan; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles	1995
Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. The Journal of biological chemistry, 1996, Sep-06, Volume: 271, Issue:36 Topics: Alkaloids; Angiotensin II; Animals; Aorta; Calcium Channels; Carbazoles; Colforsin; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Indoles; Inositol 1,4,5-Trisphosphate Receptors; Male; Nitroprusside; Phosphorylation; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Thionucleotides; Time Factors	1996
Physiological role of large, Ca2+-activated K+ channels in human glomerular mesangial cells. Clinical and experimental pharmacology & physiology, 1996, Volume: 23, Issue:1 Topics: Angiotensin II; Arachidonic Acid; Calcium; Cells, Cultured; Cyclic GMP; Glomerular Mesangium; Glucose; Humans; Patch-Clamp Techniques; Potassium Channels	1996
Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. The American journal of physiology, 1996, Volume: 271, Issue:1 Pt 1 Topics: Angiotensin II; Animals; Blood Pressure; Calcium; Cyclic GMP; Drug Resistance; Erythropoietin; Hematocrit; Hypertension; Intracellular Membranes; Kidney Failure, Chronic; Male; Nitric Oxide; Nitroprusside; Osmolar Concentration; Penicillamine; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Vasodilation; Vasodilator Agents	1996
Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. British journal of pharmacology, 1996, Volume: 118, Issue:3 Topics: Angiotensin II; Cyclic GMP; Dose-Response Relationship, Drug; Epoprostenol; Humans; Muscle Contraction; Nitric Oxide; Saphenous Vein; Time Factors	1996
Role of large Ca(2+)-activated K+ channels in regulation of mesangial contraction by nitroprusside and ANP. The American journal of physiology, 1996, Volume: 270, Issue:6 Pt 1 Topics: Angiotensin II; Atrial Natriuretic Factor; Calcium; Cells, Cultured; Cyclic GMP; Dibutyryl Cyclic GMP; Glomerular Mesangium; Humans; Nitroprusside; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels; Vasodilator Agents	1996
Endothelial vasodilator production by uterine and systemic arteries. I. Effects of ANG II on PGI2 and NO in pregnancy. The American journal of physiology, 1996, Volume: 270, Issue:6 Pt 2 Topics: Angiotensin II; Animals; Arteries; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Female; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Omentum; Pregnancy; Pregnancy, Animal; Sheep; Uterus; Vasodilator Agents	1996
Left ventricle haemodynamics and vaso-active hormones during graded supine exercise in healthy male subjects. European journal of applied physiology and occupational physiology, 1995, Volume: 72, Issue:1-2 Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Cardiac Output; Cyclic GMP; Dopamine; Epinephrine; Exercise; Hemodynamics; Hormones; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Stroke Volume; Supine Position; Ventricular Function, Left	1995
The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion. Cardiovascular research, 1996, Volume: 32, Issue:2 Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Female; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium	1996
Stimulation of angiotensin II AT1 receptors in rat median eminence increases phosphoinositide hydrolysis. Brain research, 1995, Dec-24, Volume: 705, Issue:1-2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cyclic AMP; Cyclic GMP; Estrogens; Female; Guanine; Guanosine 5'-O-(3-Thiotriphosphate); Hydrolysis; Male; Median Eminence; Ovariectomy; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Second Messenger Systems	1995
Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circulation research, 1996, Volume: 79, Issue:4 Topics: Angiotensin II; Animals; Apoptosis; Cells, Cultured; Cyclic GMP; Humans; Muscle, Smooth, Vascular; Nitric Oxide; Rabbits; Vasoconstrictor Agents	1996
Twenty-four-hour ambulatory blood pressure and vasoactive hormones in valvular aortic disease. Blood pressure, 1996, Volume: 5, Issue:5 Topics: Adult; Aged; Aldosterone; Angiotensin II; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cyclic GMP; Endothelins; Female; Heart Rate; Hormones; Humans; Male; Middle Aged; Renin	1996
A study on regulating factors of plasma refilling during hemodialysis. Nephron, 1996, Volume: 74, Issue:1 Topics: Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Vessels; Cyclic AMP; Cyclic GMP; Endothelins; Female; Fluid Shifts; Glomerulonephritis; Hematocrit; Hemodynamics; Humans; Male; Middle Aged; Nephrosclerosis; Plasma; Polycystic Kidney Diseases; Renal Dialysis; Vasopressins; Water	1996
Renin-angiotensin system modulates renal bradykinin production. The American journal of physiology, 1996, Volume: 271, Issue:4 Pt 2 Topics: Angiotensin II; Animals; Biphenyl Compounds; Bradykinin; Cyclic GMP; Dinoprostone; Dogs; Drug Combinations; Extracellular Space; Female; Hemodynamics; Imidazoles; Kidney; Losartan; Microdialysis; Oligopeptides; Renal Circulation; Renin-Angiotensin System; Tetrazoles	1996
Angiotensin II-stimulated phospholipase C responses of two vascular smooth muscle-derived cell lines. Role of cyclic GMP. Hypertension (Dallas, Tex. : 1979), 1996, Volume: 28, Issue:5 Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Cyclic GMP; Drug Interactions; Inositol 1,4,5-Trisphosphate; Muscle, Smooth, Vascular; Penicillamine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; S-Nitroso-N-Acetylpenicillamine; Species Specificity; Type C Phospholipases; Vasodilator Agents	1996
Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:11 Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Guanylate Cyclase; Humans; Infusions, Intravenous; Male; Natriuresis; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Plasma Volume; Receptors, Atrial Natriuretic Factor; Time Factors	1996
Renal and depressor activities of inhibitors of neutral endopeptidase and angiotensin converting enzyme in monkeys infused with angiotensin II. Journal of cardiovascular pharmacology, 1996, Volume: 28, Issue:5 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Cyclic GMP; Female; Kidney; Macaca fascicularis; Neprilysin; Protease Inhibitors; Sodium	1996
Opposite regulation of Gax homeobox expression by angiotensin II and C-type natriuretic peptide. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Cyclic GMP; Down-Regulation; Drug Interactions; Gene Expression Regulation; Homeodomain Proteins; Male; Muscle Proteins; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Proteins; Rats; Rats, Wistar; RNA, Messenger	1997
Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 29, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Carcinogens; Cells, Cultured; Cyclic GMP; Endothelin-1; Enzyme Activation; Guanylate Cyclase; Muscle, Smooth, Vascular; Peptide Fragments; Protein Kinase C; Rats; Receptors, Atrial Natriuretic Factor; Tetradecanoylphorbol Acetate; Tetrahydroisoquinolines; Transfection	1997
Modulation by angiotensin II of endothelial cell control of DNA synthesis in human mesangial cells. Nephron, 1997, Volume: 75, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Bosentan; Cell Division; Cells, Cultured; Coculture Techniques; Culture Media, Conditioned; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; DNA; Endothelin Receptor Antagonists; Endothelin-1; Endothelium, Vascular; Epoprostenol; Glomerular Mesangium; Humans; Indomethacin; Sulfonamides; Thymidine; Umbilical Veins	1997
Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 281, Issue:1 Topics: Angiotensin II; Animals; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoproterenol; Male; Rats; Rats, Sprague-Dawley; Vasodilation	1997
Stimulation of angiotensin subtype 2 receptor reduces basal cGMP levels in the neointima of rat aorta after balloon injury. General pharmacology, 1997, Volume: 28, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Benzimidazoles; Biphenyl Compounds; Catheterization; Cyclic AMP; Cyclic GMP; Imidazoles; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Tunica Intima	1997
Vascular chemical sulfhydryl alkylation in vitro: alterations in intracellular calcium and cAMP and cGMP metabolism. Methods and findings in experimental and clinical pharmacology, 1997, Volume: 19, Issue:2 Topics: Acetates; Alkylation; Angiotensin II; Animals; Cadmium; Calcium; Cyclic AMP; Cyclic GMP; Ethylmaleimide; Female; Half-Life; Hypertension, Renal; Muscle, Smooth, Vascular; Norepinephrine; Potassium Chloride; Rabbits; Sulfhydryl Reagents; Vasoconstriction; Vasodilation	1997
Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP. The American journal of physiology, 1997, Volume: 272, Issue:5 Pt 2 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Dogs; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Kidney; Male; Norepinephrine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vascular Resistance	1997
Angiotensin II interacts with nitric oxide-cyclic GMP pathway in the central control of drinking behaviour: mapping with c-fos and NADPH-diaphorase. Neuroscience, 1997, Volume: 79, Issue:2 Topics: Angiotensin II; Animals; Brain; Cyclic GMP; Drinking; Male; NADPH Dehydrogenase; Nitric Oxide; Proto-Oncogene Proteins c-fos; Rats	1997
The stimulation of human neutrophil migration by angiotensin IL: its dependence on Ca2+ and the involvement of cyclic GMP. British journal of pharmacology, 1997, Volume: 121, Issue:4 Topics: Angiotensin II; Calcium; Cell Movement; Chemotaxis; Cyclic AMP; Cyclic GMP; GTP-Binding Proteins; Humans; Neutrophils	1997
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. The Journal of clinical investigation, 1997, Jul-15, Volume: 100, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Cyclic GMP; Enzyme Inhibitors; Extracellular Space; Female; Imidazoles; Indazoles; Kidney; Losartan; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; Sodium; Tetrazoles	1997
Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats. Arzneimittel-Forschung, 1997, Volume: 47, Issue:9 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Body Weight; Cerebrovascular Disorders; Cyclic GMP; Dihydropyridines; Hemodynamics; Hormones; Hypertension; Kidney; Rats; Rats, Inbred SHR; Renin; Tetrazoles	1997
Effect of nitric oxide on DNA replication induced by angiotensin II in rat cardiac fibroblasts. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:5 Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Cyclic GMP; DNA Replication; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Inhibitors; Fibroblasts; Immediate-Early Proteins; Myocardium; Nitric Oxide; Nitroprusside; Penicillamine; Proto-Oncogene Proteins c-fos; Rats; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Thymidine; Transcription Factors	1997
Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis. British journal of pharmacology, 1997, Volume: 122, Issue:4 Topics: Adult; Angiotensin II; Culture Media, Conditioned; Cyclic GMP; Endothelins; Endothelium, Vascular; Epoprostenol; Female; Humans; Muscle Contraction; Nitric Oxide; Nitroprusside; Varicose Veins	1997
Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Aorta, Thoracic; Cells, Cultured; Cyclic GMP; Down-Regulation; Hypertension; Kinetics; Muscle, Smooth, Vascular; Nitric Oxide; Penicillamine; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Transcription, Genetic; Transfection	1998
AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cerebrovascular Disorders; Cyclic GMP; Hypertension; Imidazoles; Losartan; Male; Minoxidil; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values	1998
Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II. Journal of cardiovascular pharmacology, 1998, Volume: 31, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Cyclic GMP; Female; Heart Failure; Hemodynamics; Myocardium; Neprilysin; Peptidyl-Dipeptidase A; Sheep; Time Factors; Ventricular Function	1998
C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism. Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 357, Issue:1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Count; Cell Division; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Enzyme Inhibitors; Glomerular Mesangium; Interleukin-1; Interleukin-6; Marine Toxins; Natriuretic Peptide, C-Type; Oxazoles; Phosphoprotein Phosphatases; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase C; Proteins; Rats; Thymidine	1998
Marked difference between angiotensin-converting enzyme and neutral endopeptidase inhibition in vivo by a dual inhibitor of both enzymes. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 284, Issue:3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cyclic GMP; Dose-Response Relationship, Drug; Kidney; Male; Neprilysin; Propionates; Rats; Rats, Sprague-Dawley; Renin; Sulfhydryl Compounds	1998
Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome. The American journal of physiology, 1998, Volume: 274, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Proteins; Blood Volume; Cyclic GMP; Doxorubicin; Glomerulonephritis; Hematocrit; Hemodynamics; Male; Nephrotic Syndrome; Rats; Rats, Sprague-Dawley	1998
Inhibition of proximal tubular fluid absorption by nitric oxide and atrial natriuretic peptide in rat kidney. The American journal of physiology, 1998, Volume: 274, Issue:4 Topics: Absorption; Angiotensin II; Animals; Atrial Natriuretic Factor; Biological Transport; Body Fluids; Cyclic GMP; Kidney; Kidney Tubules, Proximal; Male; Nitric Oxide; Nitroprusside; Punctures; Rats; Rats, Sprague-Dawley	1998
Arachidonic acid potentiates the feedback response of mesangial BKCa channels to angiotensin II. The American journal of physiology, 1998, Volume: 274, Issue:4 Topics: Angiotensin II; Arachidonic Acid; Calcium; Cells, Cultured; Cyclic GMP; Feedback; Glomerular Mesangium; Humans; Potassium Channels	1998
Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. The American journal of physiology, 1998, Volume: 275, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cyclic AMP; Cyclic GMP; Diet, Sodium-Restricted; Dinoprostone; Dose-Response Relationship, Drug; Guanethidine; Homeostasis; Imidazoles; Intestinal Absorption; Intestinal Mucosa; Jejunum; Kinetics; Losartan; Male; Mesenteric Arteries; Oligopeptides; Prazosin; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Time Factors; Water	1998
Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo. The American journal of physiology, 1998, Volume: 275, Issue:2 Topics: Acetylcholine; Angiotensin II; Animals; Arterioles; Calcimycin; Cheek; Cricetinae; Cyclic GMP; Drug Carriers; Indomethacin; Isoproterenol; Liposomes; Male; Mesocricetus; Mouth Mucosa; Nitroglycerin; Phenylephrine; Protein Structure, Secondary; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilator Agents	1998
Angiotensin II signaling activities the NO-cGMP pathway in rat proximal tubules. Life sciences, 1998, Volume: 63, Issue:4 Topics: Acrylates; Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cyclic GMP; Imidazoles; Kidney Tubules, Proximal; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiophenes	1998
Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. The American journal of physiology, 1998, Volume: 275, Issue:4 Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Angiotensin II; Animals; Bradykinin; Cardiomegaly; Cells, Cultured; Coculture Techniques; Cyclic GMP; Endothelium, Vascular; Heart; Iloprost; Indomethacin; Male; Molsidomine; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; omega-N-Methylarginine; Phenylalanine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley	1998
Control of vascular smooth muscle cell growth in fowl. General and comparative endocrinology, 1998, Volume: 112, Issue:1 Topics: Anesthesia; Angiotensin II; Animals; Aorta; Cell Division; Cells, Cultured; Chickens; Cyclic GMP; DNA; Fetal Blood; Homeostasis; Muscle, Smooth, Vascular; Norepinephrine; Penicillamine; Platelet-Derived Growth Factor	1998
Functionally active catalytic domain is essential for guanylyl cyclase-linked receptor mediated inhibition of human aldosterone synthesis. Molecular pharmacology, 1998, Volume: 54, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Bacterial Toxins; Binding Sites; Cells, Cultured; COS Cells; Cyclic GMP; Enterotoxins; Escherichia coli Proteins; Guanylate Cyclase; Humans; Immunoblotting; Iodine Radioisotopes; Kinetics; Point Mutation; Receptors, Enterotoxin; Receptors, Guanylate Cyclase-Coupled; Receptors, Peptide; Sensitivity and Specificity; Stimulation, Chemical; Transfection; Vaccinia virus	1998
Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. The Journal of pharmacology and experimental therapeutics, 1998, Volume: 287, Issue:2 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Body Weight; Bradykinin; Cyclic GMP; Diuresis; Electrolytes; Heart; Male; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Renin	1998
Chronic infusions of brain natriuretic peptide in conscious sheep: bioactivity at low physiological levels. Clinical science (London, England : 1979), 1998, Volume: 95, Issue:6 Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Function, Right; Atrial Natriuretic Factor; Cardiac Output; Creatinine; Cyclic GMP; Female; Hemodynamics; Infusions, Intravenous; Natriuresis; Natriuretic Peptide, Brain; Potassium; Random Allocation; Sheep; Time Factors	1998
Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. The American journal of physiology, 1998, Volume: 275, Issue:6 Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Glutamyl Aminopeptidase; Indomethacin; Methionyl Aminopeptidases; Methylene Blue; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pulmonary Artery; Receptors, Angiotensin; Swine; Vasodilation	1998
Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. British journal of pharmacology, 1998, Volume: 125, Issue:8 Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Aorta; Calcium; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Manganese; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Oxadiazoles; Phosphodiesterase Inhibitors; Protein Kinase C; Purinones; Quinoxalines; Rabbits; Thionucleotides; Vasoconstrictor Agents; Vasodilator Agents	1998
Compartmentalization of extracellular cGMP determines absorptive or secretory responses in the rat jejunum. The Journal of clinical investigation, 1999, Volume: 103, Issue:2 Topics: Angiotensin II; Animals; Arginine; Chlorides; Cyclic GMP; Diet, Sodium-Restricted; Enterotoxins; Imidazoles; Intestinal Absorption; Jejunum; Male; Microscopy, Fluorescence; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Sodium; Water	1999
Age-related responses of vasoactive factors during acute exercise. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1998, Volume: 30, Issue:11 Topics: Adrenomedullin; Adult; Aged; Aged, 80 and over; Aging; Angiotensin II; Atrial Natriuretic Factor; Cyclic AMP; Cyclic GMP; Exercise; Female; Humans; Male; Peptides; Reference Values; Vasodilator Agents	1998
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Circulation, 1999, Feb-16, Volume: 99, Issue:6 Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles	1999
Relaxin is a potent renal vasodilator in conscious rats. The Journal of clinical investigation, 1999, Volume: 103, Issue:4 Topics: Angiotensin II; Animals; Cyclic GMP; Female; Hematocrit; Humans; Infusions, Intra-Arterial; Kidney; NG-Nitroarginine Methyl Ester; Nitric Oxide; Osmolar Concentration; Ovariectomy; Rats; Rats, Long-Evans; Recombinant Proteins; Relaxin; Swine; Vasodilator Agents	1999
Angiotensin II-induced constrictions are masked by bovine retinal vessels. Investigative ophthalmology & visual science, 1999, Volume: 40, Issue:3 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Cattle; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Flurbiprofen; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Retinal Vessels; Saralasin; Vasoconstriction; Vasoconstrictor Agents	1999
Renal function in high-output heart failure in rats: role of endogenous natriuretic peptides. Journal of the American Society of Nephrology : JASN, 1999, Volume: 10, Issue:3 Topics: Analysis of Variance; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Kidney Function Tests; Male; Polysaccharides; Rats; Rats, Wistar; Reference Values; Renal Circulation; Statistics, Nonparametric; Urodynamics	1999
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan	1999
Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology. Circulation research, 1999, Apr-02, Volume: 84, Issue:6 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Actin Cytoskeleton; Angiotensin II; Animals; Aorta, Thoracic; Cell Movement; Cells, Cultured; Culture Media; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytoskeleton; Diffusion Chambers, Culture; Guanylate Cyclase; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myosin Heavy Chains; Natriuretic Peptide, C-Type; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Penicillamine; Quinoxalines; Rats; Rats, Sprague-Dawley	1999
Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes. The American journal of physiology, 1999, Volume: 276, Issue:5 Topics: Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cells, Cultured; Chelating Agents; Cyclic GMP; Enzyme Inhibitors; Female; Heart Ventricles; Imidazoles; Indoles; Lipopolysaccharides; Losartan; Male; Mitochondria; Muscle Fibers, Skeletal; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rabbits; Receptors, Angiotensin; Sepsis; Ventricular Function	1999
Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:5 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cyclic GMP; Hypertension, Renovascular; Imidazoles; Kidney; Losartan; Nitric Oxide; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Vasodilation	1999
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proceedings of the National Academy of Sciences of the United States of America, 1999, May-25, Volume: 96, Issue:11 Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Cyclic GMP; Diet, Sodium-Restricted; Homozygote; Kidney; Mice; Mice, Knockout; Microdialysis; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sodium; Time Factors; X Chromosome	1999
Adventitia-dependent relaxations of canine basilar arteries transduced with recombinant eNOS gene. The American journal of physiology, 1999, Volume: 276, Issue:6 Topics: Angiotensin II; Animals; Basilar Artery; Blood Physiological Phenomena; Cyclic GMP; Dogs; Gene Transfer Techniques; In Vitro Techniques; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Recombinant Proteins; Substance P; Vasodilation	1999
Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. Circulation research, 1999, Jun-25, Volume: 84, Issue:12 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenoviridae; Angiotensin II; Animals; Antimetabolites, Antineoplastic; beta-Galactosidase; Bleomycin; Blood Flow Velocity; Blood Pressure; Bradykinin; Cyclic GMP; Endothelin-1; Gene Transfer Techniques; Genes, Reporter; Hypertension, Pulmonary; Hypoxia; Mice; Mice, Inbred Strains; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; Phosphodiesterase Inhibitors; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Purinones; Sympathomimetics; Vasoconstrictor Agents	1999
Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation. Molecular and cellular endocrinology, 1999, Jul-20, Volume: 153, Issue:1-2 Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Cell Line; Colforsin; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hydroxycholesterols; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; PC12 Cells; Quinoxalines; Rats	1999
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. The Journal of clinical investigation, 1999, Volume: 104, Issue:7 Topics: Actins; Amiloride; Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cell Membrane; Cyclic GMP; Endothelium, Vascular; Imidazoles; Kinins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Promoter Regions, Genetic; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; Tunica Media; Vasoconstriction; Vasodilation	1999
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt. Cardiovascular research, 1999, Volume: 42, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Heart Failure; Male; Myocardium; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Statistics, Nonparametric; Tetrazoles; Valine; Valsartan	1999
Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells. Thrombosis and haemostasis, 1999, Volume: 82, Issue:5 Topics: Angiotensin II; Animals; Blotting, Northern; Cells, Cultured; Culture Media, Conditioned; Cyclic GMP; Endothelium, Vascular; Gene Expression Regulation; Lipopolysaccharides; Lipoproteins; Male; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; RNA, Messenger; Second Messenger Systems; Thionucleotides; Thrombin; Thromboplastin; Tissue Plasminogen Activator	1999
Identification of G protein-coupled signaling pathways in cardiac fibroblasts: cross talk between G(q) and G(s). American journal of physiology. Cell physiology, 2000, Volume: 278, Issue:1 Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Angiotensin II; Animals; Bradykinin; Calcium; Carbachol; Cardiotonic Agents; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; Fibroblasts; GTP-Binding Protein alpha Subunits, Gq-G11; GTP-Binding Protein alpha Subunits, Gs; GTP-Binding Proteins; Inositol 1,4,5-Trisphosphate; Isoproterenol; Male; Myocardium; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Signal Transduction; Sympathomimetics; Type C Phospholipases; Uridine Triphosphate; Vasoconstrictor Agents	2000
Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochemical and biophysical research communications, 2000, May-10, Volume: 271, Issue:2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Division; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Endothelin-1; Enzyme Inhibitors; Fibroblast Growth Factors; Glomerular Mesangium; Guanylate Cyclase; Mitogen-Activated Protein Kinase 1; Peptide Fragments; Platelet-Derived Growth Factor; Precipitin Tests; Protein Kinase Inhibitors; Protein Kinases; Rats; Receptors, Atrial Natriuretic Factor; Tetrahydroisoquinolines; Thymidine; Time Factors; Transfection	2000
Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells. Biochemical and biophysical research communications, 2000, Jun-07, Volume: 272, Issue:2 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Binding, Competitive; Biphenyl Compounds; Catecholamines; Cells, Cultured; Chromaffin Cells; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Induction; Imidazoles; Oligopeptides; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Swine; Tetrazoles; Tyrosine 3-Monooxygenase	2000
Endothelial dysfunction limits the antihypertrophic action of bradykinin in rat cardiomyocytes. Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:6 Topics: Angiotensin II; Animals; Bradykinin; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Heart; Male; Myocardium; Rats; Rats, Sprague-Dawley	2000
AT(1) and AT(2) receptors in the kidney: role in disease and treatment. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1 Topics: Absorption; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Apoptosis; Arterioles; Body Water; Bradykinin; Cell Differentiation; Cell Division; Collagen; Cyclic GMP; Humans; Kidney; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Nitric Oxide; Receptors, Angiotensin; Renin-Angiotensin System; Sodium; Vasoconstriction; Vasodilation	2000
Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure. Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:4 Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiovascular Agents; Cross-Over Studies; Cyclic GMP; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Injections, Intravenous; Kidney; Natriuretic Peptide, Brain; Pyridines; Renin; Sheep; Sodium; Thiazepines	2000
Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release. American journal of physiology. Lung cellular and molecular physiology, 2000, Volume: 279, Issue:5 Topics: Angiotensin II; Animals; Calcium; Cell Membrane; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Culture Techniques; Pulmonary Artery; Receptors, Angiotensin; Swine; Vasodilation	2000
Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat. American journal of hypertension, 2000, Volume: 13, Issue:12 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Body Weight; Cardiovascular System; Collagen; Cyclic GMP; DNA; Drinking; Enalapril; Fibrosis; Losartan; Male; Myocardium; NADPH Dehydrogenase; Rats; Rats, Wistar; Reference Values; Systole; Time Factors	2000
NO/cGMP signaling modulates regulation of Na+-K+-ATPase activity by angiotensin II in rat proximal tubules. American journal of physiology. Renal physiology, 2001, Volume: 280, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Calcium; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Intracellular Membranes; Kidney Tubules, Proximal; Male; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Solubility	2001
Role of nitric oxide on atrial natriuretic peptide release induced by angiotensin II in superfused rat atrial tissue. Regulatory peptides, 2001, Apr-20, Volume: 98, Issue:3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Heart Atria; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Perfusion; Radioimmunoassay; Rats; Rats, Sprague-Dawley	2001
Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells. American journal of physiology. Renal physiology, 2001, Volume: 280, Issue:6 Topics: Angiotensin II; Animals; Binding, Competitive; Calcium; Cyclic AMP; Cyclic GMP; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Focal Adhesion Protein-Tyrosine Kinases; Iodine Radioisotopes; Kidney Tubules, Proximal; LLC-PK1 Cells; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Renin-Angiotensin System; Signal Transduction; Swine; Thymidine; Tritium; Tyrosine	2001
Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:5 Topics: Actins; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autacoids; Blood Pressure; Blotting, Western; Bradykinin; Cyclic GMP; Female; Kidney; Oligodeoxyribonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger	2001
[The role of nitric oxide in the prevention of myocardial hypertrophic response and its mechanisms]. Sheng li ke xue jin zhan [Progress in physiology], 2000, Volume: 31, Issue:4 Topics: Academic Dissertations as Topic; Angiotensin II; Animals; Cardiomyopathy, Hypertrophic; Cyclic GMP; Endothelin-1; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Proto-Oncogene Proteins c-fos; Rats; Ventricular Pressure	2000
ANPs effect on MARCKS and StAR phosphorylation in agonist-stimulated glomerulosa cells. Molecular and cellular endocrinology, 2001, May-25, Volume: 177, Issue:1-2 Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Cattle; Cyclic GMP; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Phosphoproteins; Phosphorus Radioisotopes; Phosphorylation; Potassium; Protein Kinase C; Zona Glomerulosa	2001
Angiotensin regulates endothelin-B receptor in rat inner medullary collecting duct. Metabolism: clinical and experimental, 2001, Volume: 50, Issue:6 Topics: Angiotensin II; Animals; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Endothelin-1; In Vitro Techniques; Kidney Medulla; Kidney Tubules, Collecting; Male; Protein Binding; Protein Kinase C; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; RNA, Messenger	2001
Cyclic AMP elevating agents and nitric oxide modulate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. British journal of pharmacology, 2001, Volume: 133, Issue:4 Topics: Analysis of Variance; Angiotensin II; Animals; Cell Communication; Cells, Cultured; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Leukocytes; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley	2001
Activation of angiotensin II subtype 2 receptor induces catecholamine release in an extracellular Ca(2+)-dependent manner through a decrease of cyclic guanosine 3',5'-monophosphate production in cultured porcine adrenal medullary chromaffin Cells. Endocrinology, 2001, Volume: 142, Issue:7 Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium; Catecholamines; Cells, Cultured; Chromaffin Cells; Cyclic GMP; Extracellular Space; Imidazoles; Inositol 1,4,5-Trisphosphate; Intracellular Membranes; Oligopeptides; Pyridines; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Swine; Tetrazoles; Virulence Factors, Bordetella	2001
Sustained influence of the renal nerves to attenuate sodium retention in angiotensin hypertension. American journal of physiology. Regulatory, integrative and comparative physiology, 2001, Volume: 281, Issue:2 Topics: Angiotensin II; Animals; Baroreflex; Blood Pressure; Creatinine; Cyclic GMP; Denervation; Dogs; Female; Heart Rate; Hemodynamics; Hypertension; Kidney; Potassium; Sodium; Sympathetic Nervous System	2001
Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 38, Issue:2 Topics: Angiotensin II; Animals; Animals, Newborn; Cells, Cultured; Cyclic GMP; Drug Antagonism; Fibroblasts; Kinetics; Myocardium; Nitric Oxide; Penicillamine; Rats; Rats, Sprague-Dawley; RNA Stability; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta3	2001
Angiotensin subtype-2 receptor (AT2 ) negatively regulates subtype-1 receptor (AT1 ) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells. Journal of hypertension, 2001, Volume: 19, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Chromaffin Cells; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA-Binding Proteins; Drug Combinations; Enzyme Activation; Imidazoles; Isoenzymes; Milk Proteins; Mitogen-Activated Protein Kinases; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; STAT5 Transcription Factor; Swine; Tetrazoles; Trans-Activators	2001
Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation, 2001, Nov-06, Volume: 104, Issue:19 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Aorta; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Induction; In Vitro Techniques; Isoenzymes; Male; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation; Vasodilator Agents; Vinca Alkaloids	2001
Effects of adrenomedullin on hypertrophic responses induced by angiotensin II, endothelin-1 and phenylephrine. Peptides, 2001, Volume: 22, Issue:11 Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic AMP; Cyclic GMP; Drug Interactions; Endothelin-1; Gene Expression; Heart; Heart Ventricles; In Vitro Techniques; Myocardium; Natriuretic Peptide, Brain; Peptides; Phenylephrine; Rats; Sarcomeres	2001
Vessel-specific stimulation of protein synthesis by nitric oxide synthase inhibition: role of extracellular signal-regulated kinases 1/2. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:1 Topics: Angiotensin II; Animals; Aorta; Autoradiography; Blood Pressure; Cyclic GMP; Enzyme Inhibitors; Mesenteric Arteries; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Renin; Stimulation, Chemical	2002
Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:1 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cyclic GMP; Enzyme Inhibitors; Growth Hormone; Heart; Heart Failure; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Wistar; Recombinant Proteins; RNA, Messenger; Ventricular Dysfunction, Left	2002
Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:1 Topics: Adrenomedullin; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic AMP; Cyclic GMP; Dipeptides; Drug Synergism; Female; Heart Failure; Hemodynamics; Kidney; Natriuretic Peptide, Brain; Neprilysin; Peptides; Protease Inhibitors; Renin; Sheep; Vasodilator Agents	2002
Angiotensin II type 2 receptor counter-regulates type 1 receptor in catecholamine synthesis in cultured porcine adrenal medullary chromaffin cells. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:1 Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Catecholamines; Cells, Cultured; Cyclic GMP; Imidazoles; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Swine; Tetrazoles; Tyrosine 3-Monooxygenase	2002
1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. Peptides, 2002, Volume: 23, Issue:1 Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Cyclic GMP; Dinoprostone; Epoprostenol; Hypertension; Male; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Salts; Thromboxane A2; Thromboxane B2; Time Factors	2002
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circulation research, 2002, Mar-08, Volume: 90, Issue:4 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Activation; Guanylate Cyclase; In Vitro Techniques; Infusions, Parenteral; Membrane Glycoproteins; Membrane Transport Proteins; Microfilament Proteins; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Dehydrogenase; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphoproteins; Protein Kinase C; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides; Vasodilation; Vasodilator Agents	2002
[The influence of nasal continual positive airway pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2002, Volume: 25, Issue:1 Topics: Angiotensin II; Cyclic AMP; Cyclic GMP; Endothelin-1; Positive-Pressure Respiration; Renin; Sleep Apnea, Obstructive; Thromboxane B2	2002
Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP. Journal of hypertension, 2002, Volume: 20, Issue:6 Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cyclic GMP; Extracellular Space; Female; Imidazoles; Injections, Intravenous; Kidney; Losartan; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan	2002
Effects of angiotensin II on the renal interstitial concentrations of NO2/NO3 and cyclic GMP in anesthetized rats. Japanese journal of pharmacology, 2002, Volume: 88, Issue:4 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Cyclic GMP; Extracellular Space; Kidney; Male; Microdialysis; Nitrates; Nitrites; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation	2002
Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells. Molecular and cellular biochemistry, 2002, Volume: 233, Issue:1-2 Topics: Angiotensin II; Atrial Natriuretic Factor; Autopsy; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Guanylate Cyclase; Humans; Mitogen-Activated Protein Kinase 1; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Receptors, Atrial Natriuretic Factor; Signal Transduction; Time Factors; Transfection	2002
Role of C-terminal cytoplasmic domain of the AT2 receptor in ligand binding and signaling. FEBS letters, 2002, Jul-31, Volume: 524, Issue:1-3 Topics: Amino Acid Sequence; Angiotensin II; Animals; Base Sequence; Codon, Terminator; Cyclic GMP; DNA Primers; Humans; Ligands; Molecular Sequence Data; Protein Binding; Receptors, Angiotensin; Sequence Homology, Amino Acid; Signal Transduction; Xenopus	2002
Angiotensin II stimulates basolateral K channels in rat cortical collecting ducts. American journal of physiology. Renal physiology, 2003, Volume: 284, Issue:1 Topics: Angiotensin II; Animals; Cyclic GMP; Enzyme Inhibitors; Kidney Cortex; Kidney Tubules, Collecting; Male; Membrane Potentials; NG-Nitroarginine Methyl Ester; Nitric Oxide; Patch-Clamp Techniques; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Specific Pathogen-Free Organisms; Vasoconstrictor Agents	2003
Effect of angiotensin II on ANP-dependent guanylyl cyclase activity in cultured mouse and rat podocytes. Kidney & blood pressure research, 2002, Volume: 25, Issue:5 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Line, Transformed; Cells, Cultured; Cyclic GMP; Female; Guanylate Cyclase; In Vitro Techniques; Kidney Glomerulus; Mice; Rats; Rats, Wistar	2002
Nitric oxide decreases the production of inositol phosphates stimulated by angiotensin II and thyrotropin-releasing hormone in anterior pituitary cells. European journal of endocrinology, 2003, Volume: 148, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Guanylate Cyclase; Inositol Phosphates; Male; Nitric Oxide; Nitric Oxide Donors; Pituitary Gland, Anterior; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone; Vasoconstrictor Agents	2003
Neuroendocrine control of body fluid homeostasis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2003, Volume: 36, Issue:2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Drinking; Guanylate Cyclase; Homeostasis; Humans; Hypothalamus; Natriuresis; Natriuretic Agents; Oxytocin; Rats; Water-Electrolyte Balance	2003
Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovascular research, 2003, Volume: 57, Issue:2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Cyclic GMP; Drug Interactions; Guanylate Cyclase; Male; Muscle Cells; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor	2003
Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation, 2003, Feb-18, Volume: 107, Issue:6 Topics: Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Cultured; Coculture Techniques; Cyclic GMP; Cytochrome P-450 CYP11B2; Gene Expression; Myocytes, Cardiac; Natriuretic Peptide, Brain; Polysaccharides; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2003
Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle. Circulation research, 2003, Mar-07, Volume: 92, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amides; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Hypertension; Indoles; Intracellular Signaling Peptides and Proteins; Maleimides; Muscle Proteins; Muscle, Smooth, Vascular; Myosin-Light-Chain Phosphatase; NG-Nitroarginine Methyl Ester; Phosphoprotein Phosphatases; Phosphoproteins; Phosphorylation; Protein Kinase C; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Threonine	2003
Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries. The Journal of physiology, 2003, May-01, Volume: 548, Issue:Pt 3 Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cell Membrane Permeability; Cyclic GMP; Enalaprilat; Endothelium, Vascular; In Vitro Techniques; Kinetics; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nitroarginine; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Thiazepines; Vasodilation	2003
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats. The international journal of biochemistry & cell biology, 2003, Volume: 35, Issue:6 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Losartan; Male; Minoxidil; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2003
Contribution of bradykinin and nitric oxide to AT2 receptor-mediated differentiation in PC12 W cells. Journal of neurochemistry, 2003, Volume: 85, Issue:3 Topics: Alkaloids; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Bradykinin; Carbazoles; Cell Count; Cell Differentiation; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Indoles; Neurites; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; PC12 Cells; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	2003
Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats. American journal of hypertension, 2003, Volume: 16, Issue:5 Pt 1 Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Buthionine Sulfoximine; Cyclic AMP; Cyclic GMP; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; F2-Isoprostanes; Glutathione; Heart Rate; Hypertension; Kidney; Losartan; Male; Models, Cardiovascular; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Thromboxane A2; Treatment Outcome	2003
Alternative splicing of cGMP-dependent protein kinase I and nitrate tolerance. Circulation research, 2003, Nov-28, Volume: 93, Issue:11 Topics: Alternative Splicing; Angiotensin II; Animals; Basilar Artery; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; DNA, Complementary; Drug Tolerance; Hypertension; Introns; Isoenzymes; Muscle, Smooth, Vascular; Nitrates; Rats; Reproducibility of Results; RNA, Messenger	2003
Atrial natriuretic peptide ameliorates hypoxic pulmonary vasoconstriction without influencing systemic circulation. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2003, Volume: 54, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Circulation; Blood Gas Analysis; Cyclic GMP; Dogs; Drug Administration Schedule; Hemodynamics; Hydrogen-Ion Concentration; Hypoxia; Infusions, Intravenous; Oxygen; Pulmonary Artery; Pulmonary Circulation; Pulmonary Gas Exchange; Renin; Time Factors; Vascular Resistance; Vasoconstriction	2003
Differential regulation by AT(1) and AT(2) receptors of angiotensin II-stimulated cyclic GMP production in rat uterine artery and aorta. British journal of pharmacology, 2004, Volume: 141, Issue:6 Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta; Arteries; Cyclic GMP; Female; In Vitro Techniques; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Uterus; Vasoconstrictor Agents	2004
Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation, 2004, May-18, Volume: 109, Issue:19 Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Biphenyl Compounds; Child; Child, Preschool; Coronary Circulation; Coronary Vessels; Cyclic GMP; Female; Humans; Imidazoles; Irbesartan; Male; Microcirculation; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; RNA, Messenger; Tetrazoles; Vasodilation	2004
Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Valve Stenosis; Bradykinin; Bradykinin B2 Receptor Antagonists; Cyclic GMP; Hypertension; Imidazoles; Ligation; Losartan; Male; Mice; Mice, Inbred ICR; Models, Animal; Nitric Oxide; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Renin; RNA, Messenger; Up-Regulation; Vasoconstriction	2004
RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2004, Volume: 27, Issue:4 Topics: Angiotensin II; Animals; Antihypertensive Agents; Aorta; Cells, Cultured; Cyclic AMP; Cyclic GMP; Hypertension; Muscle, Smooth, Vascular; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Stroke; Tetrazoles; Valine; Valsartan	2004
Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:8 Topics: Adult; Angiotensin II; Bartter Syndrome; Case-Control Studies; Cohort Studies; Creatinine; Cyclic GMP; Female; Gene Expression; Humans; Hypertension; Middle Aged; Monocytes; Nitrates; Nitrites; RGS Proteins; RNA, Messenger; Vasomotor System	2004
Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling. Journal of molecular and cellular cardiology, 2005, Volume: 38, Issue:1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Male; Muscle, Smooth, Vascular; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Transcription, Genetic; Up-Regulation	2005
Activation of protein kinase A by atrial natriuretic peptide in neonatal rat cardiac fibroblasts: role in regulation of the local renin-angiotensin system. Regulatory peptides, 2005, Dec-15, Volume: 132, Issue:1-3 Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Newborn; Atrial Natriuretic Factor; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Fibroblasts; Gene Expression Regulation; Indoles; Myocardium; Protein Kinase Inhibitors; Rats; Renin; Renin-Angiotensin System; RNA, Messenger; Up-Regulation	2005
Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells. American journal of hypertension, 2005, Volume: 18, Issue:10 Topics: Aminoquinolines; Angiotensin II; Animals; Cell Movement; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Glycoproteins; Guanylate Cyclase; Insulin; Male; Muscle, Smooth, Vascular; NADPH Oxidases; Nitric Oxide Donors; Onium Compounds; Penicillamine; Rats; Rats, Sprague-Dawley; Superoxides; Vasoconstrictor Agents	2005
Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta. British journal of pharmacology, 2006, Volume: 147, Issue:3 Topics: Angiotensin II; Animals; Aorta; Calcium; Catechin; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Male; Norepinephrine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred WKY; Vasodilation	2006
Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway. American journal of physiology. Renal physiology, 2006, Volume: 290, Issue:6 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Cyclic GMP; Diuresis; Enzyme Inhibitors; Glomerular Filtration Rate; Kidney Tubules, Proximal; Male; Natriuresis; Nitrates; Nitric Oxide; Nitrites; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase	2006
[In vitro effects of cAMP- and cGMP-stimulating drugs on the relaxation of the prostate smooth muscle tissue contraction induced by endothelin-1]. Georgian medical news, 2006, Issue:131 Topics: Adenylyl Cyclases; Aged; Angiotensin II; Colforsin; Cyclic AMP; Cyclic GMP; Endothelin-1; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth; Nitric Oxide Donors; Nitroprusside; Prostate; S-Nitrosoglutathione; Signal Transduction	2006
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5 Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Calcium Channel Blockers; Cyclic GMP; Drug Therapy, Combination; Gene Expression Regulation; Interleukin-6; Male; Myocardial Ischemia; NF-kappa B; Nitric Oxide; Rats; Rats, Inbred Lew; RNA, Messenger; Tumor Necrosis Factor-alpha	2006
Role of probucol on endothelial dysfunction of epicardial coronary arteries associated with left ventricular hypertrophy. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5 Topics: Angiotensin II; Animals; Antioxidants; Bradykinin; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Fibrosis; Hypertrophy, Left Ventricular; In Vitro Techniques; Lipid Peroxides; Male; Myocytes, Cardiac; Nitrates; Nitrites; Probucol; Serotonin; Superoxide Dismutase; Swine; Vasodilation	2006
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:4 Topics: Acridines; Adrenergic beta-Antagonists; Angiotensin II; Animals; Benzopyrans; Blood Vessels; Cell Line; Cyclic GMP; Dicarbethoxydihydrocollidine; Endothelium, Vascular; Ethanolamines; Fluorescence; Hemoglobins; Humans; Luminescence; Luminescent Agents; Luminol; Male; Myocardium; NADPH Oxidases; Nebivolol; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Phosphoproteins; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Signal Transduction; Superoxides	2006
Urocortin 1 modulates the neurohumoral response to acute nitroprusside-induced hypotension in sheep. Clinical science (London, England : 1979), 2007, Volume: 112, Issue:9 Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Corticotropin-Releasing Hormone; Cyclic GMP; Heart Rate; Hypotension; Natriuretic Peptide, Brain; Nitroprusside; Sheep; Urocortins	2007
Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:4 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Imidazoles; Nitric Oxide Donors; Podocytes; Pyridines; Radioimmunoassay; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; S-Nitroso-N-Acetylpenicillamine; Saralasin	2006
Novel nitric oxide synthase--dependent mechanism of vasorelaxation in small arteries from hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:4 Topics: Acetylcholine; Angiotensin II; Animals; Antioxidants; Aorta; Arteries; Blood Pressure; Cyclic GMP; Drug Combinations; Hydrogen Peroxide; Hypertension; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium Chloride; Vasodilation; Vasodilator Agents	2007
CD59 or C3 are not requred for angiotensin II-dependent hypertension or hypertrophy in mice. Immunology, 2007, Volume: 121, Issue:4 Topics: Angiotensin II; Animals; Aorta, Thoracic; Body Weight; Cardiomegaly; CD59 Antigens; Complement Activation; Complement C3; Cyclic GMP; Dose-Response Relationship, Drug; Hypertension; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Platelet Endothelial Cell Adhesion Molecule-1; Receptor, Angiotensin, Type 1; Tissue Culture Techniques	2007
B-Type natriuretic peptide inhibited angiotensin II-stimulated cholesterol biosynthesis, cholesterol transfer, and steroidogenesis in primary human adrenocortical cells. Endocrinology, 2007, Volume: 148, Issue:8 Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Angiotensin II; Cell Line, Tumor; Cells, Cultured; Cholesterol; Cyclic GMP; Drug Interactions; Gene Expression Profiling; Gene Expression Regulation; Humans; Lipoproteins; Male; Middle Aged; Natriuretic Peptide, Brain; Oligonucleotide Array Sequence Analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Steroids; Vasoconstrictor Agents	2007
Resveratrol inhibits proliferation of cultured rat cardiac fibroblasts: correlated with NO-cGMP signaling pathway. European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Cell Proliferation; Cell Size; Cells, Cultured; Cyclic GMP; Fibroblasts; Intracellular Space; L-Lactate Dehydrogenase; Male; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes	2007
(-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochemical and biophysical research communications, 2007, Aug-03, Volume: 359, Issue:3 Topics: Acetophenones; Angiotensin II; Catechin; Cells, Cultured; Cyclic GMP; Endothelial Cells; Enzyme Inhibitors; Humans; Methylation; Molecular Structure; NADPH Oxidases; Nitric Oxide; Signal Transduction; Umbilical Cord	2007
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiological genomics, 2007, Oct-22, Volume: 31, Issue:2 Topics: Angiotensin II; Animals; Captopril; Cardiomegaly; Cyclic GMP; Fibrosis; Gene Expression Regulation; Guanylate Cyclase; Heart Ventricles; Hydralazine; Hypertension; Interleukin-6; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Signal Transduction; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha	2007
NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2007, Volume: 293, Issue:4 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Cyclic GMP; Gene Expression Regulation; Kidney; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; RNA, Messenger; Sodium	2007
WB1106, a novel nitric oxide-releasing derivative of telmisartan, inhibits hypertension and improves glucose metabolism in rats. European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Cyclic GMP; Diet; Dietary Carbohydrates; Dietary Fats; Glucose; Insulin Resistance; Male; Muscle Contraction; Muscle Relaxation; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Telmisartan; Vasoconstriction; Vasoconstrictor Agents	2007
Fosinopril prevents the pulmonary arterial remodeling in sinoaortic-denervated rats by regulating phosphodiesterase. Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Cyclic GMP; Denervation; Fosinopril; Gene Expression Regulation; Male; Nitric Oxide Synthase Type III; Phosphoric Diester Hydrolases; Pulmonary Artery; Rats; Rats, Sprague-Dawley	2008
[Inhibitory effect of resveratrol on cardiac fibroblast proliferation induced by angiotensin II]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2008, Volume: 28, Issue:4 Topics: Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Cyclic GMP; Fibroblasts; Gene Expression; Heart; Myocardium; Nitric Oxide; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes	2008
Dissociation between superoxide accumulation and nitroglycerin-induced tolerance. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 327, Issue:1 Topics: Angiotensin II; Animals; Aorta; Cyclic GMP; Drug Tolerance; LLC-PK1 Cells; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Nitroglycerin; Superoxides; Vasodilation	2008
Alternative splicing of the guanylyl cyclase-A receptor modulates atrial natriuretic peptide signaling. The Journal of biological chemistry, 2008, Oct-17, Volume: 283, Issue:42 Topics: Alternative Splicing; Angiotensin II; Animals; Atrial Natriuretic Factor; Cell Line; Cyclic GMP; Humans; Lung; Mice; Mice, Inbred C57BL; Models, Biological; Peptides; Rats; Receptors, Atrial Natriuretic Factor; Signal Transduction	2008
Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling. Hypertension (Dallas, Tex. : 1979), 2008, Volume: 52, Issue:6 Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Buthionine Sulfoximine; Cyclic GMP; Cyclic N-Oxides; Enzyme Inhibitors; Focal Adhesion Kinase 2; Hypertension, Renal; Kidney Tubules, Proximal; Male; Mitogen-Activated Protein Kinases; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Spin Labels; Tetrazoles; Vasoconstrictor Agents	2008
Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration. Arteriosclerosis, thrombosis, and vascular biology, 2009, Volume: 29, Issue:2 Topics: Adenoviridae; Angiotensin II; Animals; Cattle; Cell Movement; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Endothelial Cells; ErbB Receptors; Genetic Vectors; GTP-Binding Protein alpha Subunits, G12-G13; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Protein Phosphatase 1; Rats; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Signal Transduction; Time Factors; Transduction, Genetic	2009
NPRA-mediated suppression of AngII-induced ROS production contribute to the antiproliferative effects of B-type natriuretic peptide in VSMC. Molecular and cellular biochemistry, 2009, Volume: 324, Issue:1-2 Topics: Angiotensin II; Animals; Aorta; Cell Proliferation; Cells, Cultured; Cyclic GMP; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Natriuretic Peptide, Brain; Rats; Reactive Oxygen Species; Receptors, Atrial Natriuretic Factor; RNA, Small Interfering	2009
Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats. Journal of hypertension, 2009, Volume: 27, Issue:3 Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Cyclic GMP; Diastole; Dose-Response Relationship, Drug; Fibrosis; Glomerulosclerosis, Focal Segmental; Hemodynamics; Hypertension; Kidney; Kidney Glomerulus; Kidney Medulla; Organ Size; Proteinuria; Rats; Rats, Inbred Dahl; Sodium; Sodium Chloride, Dietary; Systole; Time Factors; Vascular Resistance; Vasoconstriction	2009
Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels. Molecular and cellular biology, 2009, Volume: 29, Issue:22 Topics: Angiotensin II; Animals; Blood Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Fibrosis; Gene Expression Regulation; Humans; Hypertrophy; Mice; Mice, Transgenic; Muscle, Smooth, Vascular; Mutant Proteins; Organ Specificity; Phosphorylation; Phosphoserine; Protein Biosynthesis; rho-Associated Kinases; rhoA GTP-Binding Protein; Serum Response Element; Signal Transduction; Transcription, Genetic	2009
Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy. Circulation research, 2009, Nov-06, Volume: 105, Issue:10 Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Calmodulin; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Ventricles; Humans; Isoproterenol; Male; Mice; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Second Messenger Systems	2009
Early diabetes in WKY and SHR produces decrease of the responses to angiotensin II and 5-HT and changes in the NO-GMPc pathway. Clinical and experimental hypertension (New York, N.Y. : 1993), 2009, Volume: 31, Issue:5 Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Cyclic GMP; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Nitric Oxide; Nitroprusside; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Signal Transduction; Streptozocin; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents	2009
Controlling myocyte cGMP: phosphodiesterase 1 joins the fray. Circulation research, 2009, Nov-06, Volume: 105, Issue:10 Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Calmodulin; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Ventricles; Humans; Isoproterenol; Male; Mice; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Second Messenger Systems	2009
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Calcium; Cardiomegaly; Cell Size; Cells, Cultured; Cyclic GMP; Hypertension; Microscopy, Confocal; Myocytes, Cardiac; NFATC Transcription Factors; Nitric Oxide; Peptide Fragments; Protein Transport; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Signal Transduction	2010
Angiotensin-(1-7) attenuates hyposmolarity-induced ANP secretion via the Na+-K+ pump. Peptides, 2010, Volume: 31, Issue:9 Topics: Angiotensin I; Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Heart; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Nitric Oxide; Osmolar Concentration; Peptide Fragments; Perfusion; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Stress, Physiological; Time Factors	2010
Coronary vascular dysfunction promoted by oxidative-nitrative stress in SHRSP.Z-Lepr(fa) /IzmDmcr rats with metabolic syndrome. Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:11 Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Coronary Vessels; Cyclic GMP; Disease Models, Animal; Endothelium, Vascular; Insulin; Lipids; Metabolic Syndrome; Nitric Oxide; Nitroprusside; Oxidative Stress; Rats; Rats, Inbred Strains; Vasodilation	2010
Genistein prevents myocardial hypertrophy in 2-kidney 1-clip renal hypertensive rats by restoring eNOS pathway. Pharmacology, 2010, Volume: 86, Issue:4 Topics: Angiotensin II; Animals; Collagen Type I; Cyclic GMP; Gene Expression Regulation; Genistein; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Ventricular Remodeling	2010
A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:6 Topics: Acute Disease; Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Diuresis; Dogs; Glomerular Filtration Rate; Humans; Hypertension; Male; Natriuresis; Pulmonary Wedge Pressure; Renal Circulation; Vascular Resistance	2010
Antihypertensive therapy increases tetrahydrobiopterin levels and NO/cGMP signaling in small arteries of angiotensin II-infused hypertensive rats. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Biopterins; Cyclic GMP; GTP Cyclohydrolase; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Mesenteric Arteries; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reserpine; Signal Transduction	2011
Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II. PloS one, 2010, Dec-03, Volume: 5, Issue:12 Topics: Angiotensin II; Animals; Cardiomegaly; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Gene Expression Regulation, Enzymologic; Heart Ventricles; Hydrolysis; Isoenzymes; Male; Membrane Glycoproteins; Models, Biological; NADPH Oxidase 2; NADPH Oxidases; Rats; Rats, Wistar	2010
Therapeutic effects of continuous infusion of brain natriuretic peptides on postmyocardial infarction ventricular remodelling in rats. Archives of cardiovascular diseases, 2011, Volume: 104, Issue:1 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Collagen; Cyclic GMP; Disease Models, Animal; Enalapril; Hemodynamics; I-kappa B Proteins; Inflammation Mediators; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B p50 Subunit; NF-KappaB Inhibitor alpha; Phosphorylation; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling	2011
Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1. Hypertension (Dallas, Tex. : 1979), 2011, Volume: 57, Issue:3 Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Arteries; Blood Pressure; Blotting, Western; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Dose-Response Relationship, Drug; Hypertension; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasoconstriction; Vinca Alkaloids	2011
Angiotensin II upregulation of cardiomyocyte adiponectin production is nitric oxide/cyclic GMP dependent. The American journal of the medical sciences, 2011, Volume: 341, Issue:5 Topics: Adiponectin; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Models, Animal; Myocytes, Cardiac; Nitric Oxide; Rats; Rats, Wistar; Receptors, Angiotensin; Signal Transduction; Time Factors; Up-Regulation	2011
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice. British journal of pharmacology, 2011, Volume: 163, Issue:5 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydrogen Peroxide; Infusion Pumps, Implantable; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peptide Fragments; Perfusion; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Vasodilation	2011
Altered regulation of renal nitric oxide and atrial natriuretic peptide systems in angiotensin II-induced hypertension. Regulatory peptides, 2011, Oct-10, Volume: 170, Issue:1-3 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Hypertension; Kidney; Kidney Function Tests; Male; Neprilysin; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Transcription, Genetic; Tyrosine	2011
Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy. Journal of cardiovascular pharmacology, 2011, Volume: 58, Issue:3 Topics: Angiotensin II; Animals; Aorta; Atorvastatin; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Echocardiography; Endothelium, Vascular; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Nitrates; Nitrites; Pyrroles; Random Allocation; Swine; Vasodilation; Ventricular Dysfunction, Left	2011
Augmented S-nitrosylation contributes to impaired relaxation in angiotensin II hypertensive mouse aorta: role of thioredoxin reductase. Journal of hypertension, 2011, Volume: 29, Issue:12 Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cyclic GMP; Cysteine; Dinitrochlorobenzene; Disease Models, Animal; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Phenylephrine; S-Nitrosothiols; Thioredoxin-Disulfide Reductase; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents	2011
Nitric oxide inhibits the expression of AT1 receptors in neurons. American journal of physiology. Cell physiology, 2012, Apr-15, Volume: 302, Issue:8 Topics: Adenoviridae; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium; Cell Line, Tumor; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; DNA, Antisense; Hypothalamus; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitroprusside; omega-N-Methylarginine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; S-Nitroso-N-Acetylpenicillamine; Transfection	2012
Apelin secretion and expression of apelin receptors in 3T3-L1 adipocytes are differentially regulated by angiotensin type 1 and type 2 receptors. Molecular and cellular endocrinology, 2012, Apr-04, Volume: 351, Issue:2 Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Angiotensin II; Animals; Apelin; Apelin Receptors; Calcium; Cell Line; Cyclic AMP; Cyclic GMP; Flavonoids; Gene Expression Regulation; Imidazoles; Intercellular Signaling Peptides and Proteins; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Naphthyridines; Protein Kinase C; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled	2012
Restoring nitric oxide cytosolic calcium regulation by cyclic guanosine monophosphate protein kinase I alpha transfection in coronary endothelial cells of spontaneously hypertensive rats. Journal of vascular research, 2012, Volume: 49, Issue:3 Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Coronary Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytosol; Hypertension; Male; Nitric Oxide; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transfection	2012
Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. PloS one, 2012, Volume: 7, Issue:4 Topics: Angiotensin II; Animals; Cardiomegaly; Cell Adhesion Molecules; Cyclic GMP; Endothelin-1; Guanylate Cyclase; Microfilament Proteins; Myocytes, Cardiac; NADPH Oxidases; Natriuretic Peptide, Brain; Nitrites; Nitrogen Oxides; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Rats; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides	2012
Total Flavonoids of Fructus Chorspondiatis inhibits collagen synthesis of cultured rat cardiac fibroblasts induced by angiotensin II: correlated with NO/cGMP signaling pathway. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, Aug-30, Volume: 47, Issue:1 Topics: Angiotensin II; Animals; Cells, Cultured; Collagen Type I; Collagen Type III; Cyclic GMP; Drugs, Chinese Herbal; Fibroblasts; Flavonoids; Hydroxyproline; Male; Myocardium; Myofibroblasts; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plant Extracts; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction	2012
Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model. American journal of physiology. Heart and circulatory physiology, 2012, Sep-01, Volume: 303, Issue:5 Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Cell Line; Cyclic GMP; Cysteine; Disease Models, Animal; Enzyme Activation; Guanylate Cyclase; Hypertension; Male; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Nitrosation; Oxidative Stress; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Time Factors; Transfection; Vascular Resistance; Vasodilation	2012
Sodium nitrite therapy rescues ischemia-induced neovascularization and blood flow recovery in hypertension. Pflugers Archiv : European journal of physiology, 2012, Volume: 464, Issue:6 Topics: Allopurinol; Angiotensin II; Animals; Arterial Pressure; Capillaries; Cyclic AMP; Cyclic GMP; Femoral Artery; Hindlimb; Hypertension; Indoles; Ischemia; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Proto-Oncogene Proteins c-akt; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Regional Blood Flow; Sodium Nitrite; Xanthine Dehydrogenase	2012
Heparin inhibits angiotensin II-induced vasoconstriction on isolated mouse mesenteric resistance arteries through Rho-A- and PKA-dependent pathways. Vascular pharmacology, 2013, Volume: 58, Issue:4 Topics: Amides; Angiotensin II; Animals; Anticoagulants; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Heparin; Male; Mesenteric Arteries; Mice; Myosin Light Chains; Phosphorylation; Pyridines; rho-Associated Kinases; rhoA GTP-Binding Protein; Vasoconstriction	2013
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation. Blood, 2013, Apr-11, Volume: 121, Issue:15 Topics: Angiotensin I; Angiotensin II; Animals; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Cyclic AMP; Cyclic GMP; Epoprostenol; Immunoblotting; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thrombosis; Time Factors	2013
Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli. Physiology & behavior, 2013, Mar-15, Volume: 112-113 Topics: Amino Acids; Analysis of Variance; Angiotensin II; Animals; Area Postrema; Blood Glucose; Cell Count; Cross-Over Studies; Cyclic GMP; Dose-Response Relationship, Drug; Exenatide; Fasting; Feeding Behavior; Food; Gene Expression Regulation; Glucagon-Like Peptide 1; Islet Amyloid Polypeptide; Lithium Chloride; Male; Neurons; Peptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Calcitonin; Time Factors; Venoms	2013
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. Cardiovascular research, 2013, Jul-01, Volume: 99, Issue:1 Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Mesenteric Arteries; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Peptide Fragments; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilation	2013
Stimulation of ANP by angiotensin-(1-9) via the angiotensin type 2 receptor. Life sciences, 2013, Dec-05, Volume: 93, Issue:24 Topics: Algorithms; Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Atrial Natriuretic Factor; Cyclic GMP; Heart Atria; Hemodynamics; Imidazoles; Male; Nitric Oxide; Oncogene Protein v-akt; Peptide Fragments; Phosphatidylinositol 3-Kinases; Pyridines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Signal Transduction; Stimulation, Chemical	2013
Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation, 2014, Jan-28, Volume: 129, Issue:4 Topics: Angiotensin II; Animals; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Heart Ventricles; Humans; Hypertrophy; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Transgenic; Myocytes, Cardiac; Neurotransmitter Agents; Nitric Oxide Synthase; Receptors, Adrenergic, beta-3; Signal Transduction; Ventricular Remodeling	2014
Angiotensin II dose-dependently stimulates human renal proximal tubule transport by the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway. Journal of the American Society of Nephrology : JASN, 2014, Volume: 25, Issue:7 Topics: Angiotensin II; Cyclic GMP; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Kidney Tubules, Proximal; Nitric Oxide; Signal Transduction	2014
Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 2014, Sep-02, Volume: 111, Issue:35 Topics: Angiotensin II; Animals; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic Nucleotide Phosphodiesterases, Type 5; Fibrosis; Genetic Markers; Hypertension; Mice; Muscle, Smooth; Myocardial Contraction; Myocytes, Cardiac; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasoconstrictor Agents	2014
Luteolin antagonizes angiotensin II-dependent proliferation and collagen synthesis of cultured rat cardiac fibroblasts. Current pharmaceutical biotechnology, 2015, Volume: 16, Issue:5 Topics: Actins; Angiotensin II; Animals; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Collagen; Collagen Type I; Collagen Type III; Cyclic GMP; Fibroblasts; Luteolin; Myocardium; Nitric Oxide; Rats, Sprague-Dawley	2015
Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner. Pharmaceutical biology, 2015, Volume: 53, Issue:6 Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Cell Size; Cell Survival; Cyclic GMP; Flavonols; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species	2015
Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling. The Journal of pharmacology and experimental therapeutics, 2015, Volume: 354, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Fibrosis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Piperazines; Purines; Receptor, Angiotensin, Type 1; Signal Transduction; Sildenafil Citrate; Sulfonamides; Up-Regulation	2015
Predicted effects of nitric oxide and superoxide on the vasoactivity of the afferent arteriole. American journal of physiology. Renal physiology, 2015, Oct-15, Volume: 309, Issue:8 Topics: Algorithms; Angiotensin II; Animals; Arterioles; Calcium Channels, L-Type; Cyclic GMP; Cyclic N-Oxides; Enzyme Inhibitors; Free Radical Scavengers; Hypertension; Kidney; Male; Models, Statistical; Muscle, Smooth, Vascular; Myosins; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Renal Circulation; Spin Labels; Superoxides	2015
Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury. The Journal of pharmacology and experimental therapeutics, 2015, Volume: 355, Issue:1 Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cardiovascular System; Caveolin 1; Cyclic GMP; Eplerenone; Heart Injuries; Male; Mice; Mineralocorticoid Receptor Antagonists; Models, Molecular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nucleic Acid Conformation; Receptors, Mineralocorticoid; Renin-Angiotensin System; Signal Transduction; Spironolactone; Vasoconstriction; Vasodilation	2015
Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes. Molecular and cellular biochemistry, 2015, Volume: 409, Issue:1-2 Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cell Movement; Cells, Cultured; Cyclic GMP; Dexamethasone; Flow Cytometry; Mice; Nitric Oxide; Podocytes; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Atrial Natriuretic Factor; S-Nitroso-N-Acetylpenicillamine; Stress, Physiological; Vasoconstrictor Agents; Vasodilator Agents	2015
Angiotensin II-Induced Hypertension Is Attenuated by Reduction of Sympathetic Output in NO-Sensitive Guanylyl Cyclase 1 Knockout Mice. The Journal of pharmacology and experimental therapeutics, 2016, Volume: 356, Issue:1 Topics: Angiotensin II; Animals; Blood Pressure; Cyclic GMP; Guanylate Cyclase; Heart Rate; Hypertension; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Norepinephrine; Phosphoric Diester Hydrolases; Receptors, Cell Surface; Sympathetic Nervous System; Vasoconstrictor Agents; Vasodilation	2016
Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System. International journal of molecular sciences, 2015, Nov-12, Volume: 16, Issue:11 Topics: Angiotensin II; Animals; Apoptosis; Cardiopulmonary Resuscitation; Cardiotonic Agents; Cyclic GMP; Disease Models, Animal; Gene Expression Regulation; Heart Arrest; Hemodynamics; Male; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peptidyl-Dipeptidase A; Phosphodiesterase 5 Inhibitors; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sildenafil Citrate; Swine	2015
Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs. American journal of physiology. Renal physiology, 2016, 04-15, Volume: 310, Issue:8 Topics: Angiotensin II; Animals; Cyclic CMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelin-1; Hypertension; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Donors; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Solute Carrier Family 12, Member 1; Vardenafil Dihydrochloride	2016
PGC-1α ameliorates AngiotensinII-induced eNOS dysfunction in human aortic endothelial cells. Vascular pharmacology, 2016, Volume: 83 Topics: Angiotensin II; Aorta; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Nitrites; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; Serine; Transfection; Up-Regulation	2016
Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction. Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9 Topics: Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Endoplasmic Reticulum Stress; Fibrosis; Genetic Predisposition to Disease; Hypertension; Male; Mice, Knockout; Muscle, Smooth, Vascular; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Nitrites; Phenotype; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Stromal Interaction Molecule 1; Time Factors; Transcription Factor CHOP; Transforming Growth Factor beta; Vasodilation; Vasodilator Agents	2016
Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction. American journal of physiology. Renal physiology, 2017, 03-01, Volume: 312, Issue:3 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Male; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Renal Artery; Renal Circulation; Sildenafil Citrate; Vasodilation; Vasodilator Agents; Vinca Alkaloids	2017
Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4-negative mouse hearts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:4 Topics: alpha-Defensins; Angiotensin II; Animals; Cardiomegaly; Carrier Proteins; Cells, Cultured; Cyclic GMP; Heart; LIM Domain Proteins; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Zebrafish	2017
Endothelial Cells Inhibit the Angiotensin II Induced Phenotypic Modulation of Rat Vascular Adventitial Fibroblasts. Journal of cellular biochemistry, 2017, Volume: 118, Issue:7 Topics: Actins; Adventitia; Angiotensin II; Animals; Aorta, Thoracic; Arginine; Cells, Cultured; Coculture Techniques; Collagen Type I; Cyclic GMP; Endothelial Cells; Fibroblasts; Homocysteine; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Signal Transduction	2017
Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice. Vascular pharmacology, 2018, Volume: 102 Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Arterial Pressure; Cyclic GMP; Disease Models, Animal; Endothelium, Vascular; Hypertension; Male; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidase 4; Nitric Oxide; Oxidative Stress; Renal Artery; Sodium Nitrite; Tyrosine; Vasodilation	2018
MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock. Critical care medicine, 2018, Volume: 46, Issue:9 Topics: Angiotensin II; Animals; Blood Vessels; Cells, Cultured; Cyclic GMP; Endothelial Cells; Heart; Humans; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Myocardium; Nitric Oxide; Prospective Studies; Random Allocation; Shock, Septic; Signal Transduction	2018
Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Feb-01, Volume: 128 Topics: Aldosterone; Aminobutyrates; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cross-Over Studies; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Female; Heart Failure; Humans; Male; Natriuretic Peptides; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles; Valsartan	2019
Angiotensin-(1-7) induced vascular relaxation in spontaneously hypertensive rats. Nitric oxide : biology and chemistry, 2019, 07-01, Volume: 88 Topics: Angiotensin I; Angiotensin II; Animals; Arterial Pressure; Coronary Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Male; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Pulmonary Artery; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Signal Transduction; Vasodilation	2019
CRRL269. Circulation research, 2019, 05-10, Volume: 124, Issue:10 Topics: Acute Kidney Injury; Angiotensin II; Animals; Apoptosis; Biomarkers; Blood Pressure; Cyclic GMP; Diuresis; Dogs; Glomerular Filtration Rate; Male; Natriuresis; Natriuretic Peptide, C-Type; Natriuretic Peptides; Receptors, Atrial Natriuretic Factor; Renal Agents; Renal Circulation	2019
Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates renal (pro) renin receptor expression in Npr1 null mutant mice. Peptides, 2019, Volume: 114 Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cyclic GMP; Female; Kidney; Losartan; Male; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Prorenin Receptor; Receptor, Angiotensin, Type 1; Receptors, Atrial Natriuretic Factor; Receptors, Cell Surface	2019
Effects of Angiotensin-(1-7) and Angiotensin II on Acetylcholine-Induced Vascular Relaxation in Spontaneously Hypertensive Rats. Oxidative medicine and cellular longevity, 2019, Volume: 2019 Topics: Acetylcholine; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Hypertension; Male; Nitric Oxide; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilation	2019
Sodium Ferulate Inhibits Rat Cardiomyocyte Hypertrophy Induced by Angiotensin II Through Enhancement of Endothelial Nitric Oxide Synthase/Nitric Oxide/Cyclic Guanosine Monophosphate Signaling Pathway. Journal of cardiovascular pharmacology, 2022, 08-01, Volume: 80, Issue:2 Topics: Angiotensin II; Animals; Cardiomegaly; Coumaric Acids; Cyclic GMP; Esters; Guanosine Monophosphate; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Signal Transduction	2022
Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS. Scientific reports, 2022, 10-21, Volume: 12, Issue:1 Topics: Angiotensin II; Animals; Antihypertensive Agents; Cyclic GMP; Endothelium, Vascular; Guanosine Monophosphate; Hypertension; Mice; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Reactive Oxygen Species	2022
Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation. International journal of molecular sciences, 2023, May-10, Volume: 24, Issue:10 Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cyclic GMP; Guanylate Cyclase; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Rats; Receptors, Atrial Natriuretic Factor	2023